6
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 253-275 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • The Liposome Company begins orphan drug phase II trials in AIDS patients with MA (news). Oncology, 1991, 5, (4), 32.
  • Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. AEBISCHER, P., WINN, S. R., TRESCO, P. A., JAEGER, C. B., and GREENE, L. A., J. Biomech. Eng., 1991, 113, (2), 178–183.
  • Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice. AHMAD, I., SARKAR, A. K., and BACHHAWAT, B. K., Indian J. Biochem. Biophys., 1990, 27, (6), 370–374.
  • Mannosylated liposome-mediated delivery of amphotoericin B in the control of experimental aspergillosis in BALB-C mice. AHMAD, I., SARKAR, A. K., and BACHHAWAT, B. K., J. Clin. Biochem. Nutr., 1991, 10, (3), 171–180.
  • Lymph node-targeting delivery of adriamycin by liposomal administration into gastric submucosa in rabbits. AKAMO, Y., MIZUNO, I., YOTSUYANAGI, T., IcHIN0, T., YAMAMOTO, T., YASUI, T., ITABASHI, Y., TANIMOTO, N., SHINAGAWA, N., and YURA, J., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 419.
  • Endoscopic injection of liposomal adriamycin targeting lymph node metastasis of gastric cancer. AKAMO, Y., MIZUNO, I., I aim), T., YAMAMOTO, T., YASUI, T., ITABASHI, Y., SAITO, T., KURAHASHI, S., TANIMOTO, N., SHINAGAWA, N., etal., Gan. To. Kagaku Ryoho, 1991, 18, (1 1), 1822–1824.
  • Praziquantel as prophylactic in schistosomiasis formulation and stability evaluation of a liposomal delivery system. AKBARIEH, M., TAWASHI, R., GHORAB, M., and KASSEM, M., Ann. N.Y. Acad. Sci., 1991, 618 (Temporal Control of Drug Delivery), 572–574.
  • Adsorption and efflux characteristics of modified antisense oligodeoxynucleotides from liposomes. AKHTAR, S., and JuLIANo, R. L., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 332.
  • Combined effects of hepatic arterial embolization using degradable starch microspheres (DSM) in hyperthermia for liver cancer. AKUTA, K., ABE, M., KONDO, M., YOSHIKAWA, T., TANAKA, Y., YOSHIDA, M., MIURA, T., NAKAO, N., ONOYAMA, Y., YAMADA, T., et al., Int. J. Hyperthermia, 1991, 7, (2), 231–242.
  • Liposomes from laboratory to clinic: the development of liposomal drug delivery systems. ALLEN, T. M., Sapporo Med. J., 1990, 59, (6), 639–644.
  • Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. ALLEN, T. M., HANSEN, C., MARTIN, F., REDEMANN, C., and YAU-YOUNG, A., Biochim. Biophys. Acta, 1991, 1066, (1), 29–36.
  • Liposomes. The development of liposomal drug delivery systems. ALLEN, T. M., Sapporo Igaku Zasshi, 1990, 59, (6), 639–644.
  • Synthesis of protein-coated gelatin microspheres and their use as microcarriers for cell culture. Part I. Derivatization with native collagen. AITANKOV, G., BRODVAROVA, I., and RASHKOV, I., J. Biomater. Sci. Polym. Ed., 1991, 2, (2), 81–89.
  • Liposomes as carriers of antigens and adjuvants. ALvING, C. R., J. Immunol. Methods, 1991, 140, (1), 1–13.
  • Regional chemotherapy for inoperable renal carcinoma: a method of targeting therapeutic microspheres to tumour. ANDERSON, J. H., WILLMOTT, N., BESSENT, R., ANGERSON, W. J KERR, D. J., and MCARDLE, C. S., Br. J. Cancer, 1991, 64, (2), 365–368.
  • Phospholipids in oncology. ARNDT, D., Phospholipids: Biochem. Pharrn. Anal. Consid. (Proc. Int. Colloq. Lecithin), 5th, 1989, Plenum, New York, N.Y., USA, publ. 1990, pp. 177–183. Eds: I. Hanin, and G. Pepeu.
  • Effect of sodium chloride on pro-oxidant activity of copper(II) in peroxidation of phospholipid liposomes. ARNOLD, A. R., BASCETTA, E., and GUNSTONE, F. D., J. Food Sc., 1991, 56, (2), 571–573.
  • Liposomes as vehicle for allergen presentation in the immunotherapy of allergic diseases. ARORA, N., and GANGAL, S. V., Allergy (CPH), 1991, 46, (5), 386–392.
  • Liposome formation from synthetic polyhydroxyl lipids. ASSADULLAHI, T. P., HIDER, R. C., and MCAULEY, A. J., Biochim. Biophys. Acta, 1991, 1083, (3), 271–276.
  • Bioavailability of erythromycin enteric-coated microcapsules in rabbits. BAI-FENGQING, ZHAO-YANG, MA-CHUANG, YANG-YONGHUI, and QI-KUISHENG, Zhongguo Kangshengsu Zazhi, 1990, 15, (5), 382–383.
  • Calcium action on the stability of egg phosphatidylcholine sonicated vesicles during freeze-thaw cycles. BAKAS, L. S., and DISAI,VO, E. A., Cryobiology, 1991, 28, (3), 279–287. Effect of encapsulated calcium on the surface properties of curved phosphatidylcholine bilayers. BAKAS, L. S., and DISALVO, E. A., Biochim. Biophys. Acta, 1991, 1065, (2), 114–120. Liposomes and lipid carriers in the treatment of microbial infections. BAKKER-WOUDENBERG, I. A., and LOKERSE, A. F., Scand. J. Infect. Dis. Suppl., 1990, 74, 34–41.
  • Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes. BAKKER-WOUDENBERG, I. A., LOKERSE, A. F., and TEN-KATE, M., Scand. J. Infect. Dis. Suppl., 1990, 74, 54–57.
  • Metaphase chromosomes from mammalian cells stimulate fusion of artificial phospholipid vesicles. BALAKIREVA, L. A., BELYAEV, N. D., BUDKER, V. G., and KISELEVA, E. V., FEBS Lett., 1991, 284, (2), 203–205.
  • Development of microencapsulation techniques. BALDESCHWIELER, J. D., Report, 1990 (ARO-23967.5-CH; Order No. AD-A223032,), 4 pp.
  • Peritoneal influx of intravenously administered liposomal doxorubicin: a model for extravas-ation of liposomal drug carriers. BAI,LY, M. B., MAYER, L. D., and NAYAR, R., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 393.
  • Rapid magnetic microsphere enzyme immunoassay for potato virus X and potato leafroll virus. BANTTARI, E. E., CLAPPER, D. L., Hu, S. P., DAWS, K. D., and KHURANA, S. M. P., Phytopathology, 1991, 81, (9), 1039–1042.
  • Modulation of liposomal lipid peroxidation in presence of nickel by incorporation of alpha-tocopherol in the bilayer. BEHARI, J. R., GUPTA, S., SRIVASTAVA, S., and SRIVASTAVA, R. C., J. Microencapsulation, 1991, 8, (2), 215–220.
  • A neutropenic murine model developed for treatment of systemic candidiasis using liposomal amphotericin B bearing antibodies. BELAY, T., HOSPENTHAL, D., and ROGERS, A., Abstr. Gen. Meet. Am. Soc. Microbiol., 1991, 91, 408.
  • Use of liposomes, viral capsids, and nanoparticles as DNA carriers. BEETLING, W. M., GAREIS, M., PASI'AI.EEVA, V., ZIMMER, A., KREUTER, J., NURNBERG, E., and HARRER, P., Biotechnol. Appl. Biochem., 1991, 13, (3), 390–405.
  • Incorporation of liposomal phytosterols into human cells in culture: a potential in vitro model for investigating pathological effects of phytosterolemia. BIIADRA, S., and SUBBIAH, M. T. R., Biochem. Med. Metab. Biol., 1991, 46, (1), 119–124.
  • Liposomes as a model for studying the effect of UV radiations on biomembranes. BHATIA, R., VISWANATHAN, P. N., and KAKKAR, P., J. Microencapsulation, 1991, 8, (3), 349–358.
  • Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B prepar-ation. BJORKHOLM, M., KALLBERG, N., GRIMEORS, G., EKLUND, L. H., EKSBORG, S., JuNEsKANs, 0. T., and UDEN, A. M., J. Intern. Med., 1991, 230, (2), 173–177.
  • One-component polyurethane systems by deactivation of dispersed solid isocyanates. BLum, R., and SCHUPP, H., Frog. Org. Coat., 1990, 18, (3), 275–288.
  • Spontaneous formation of drug-containing acrylic nanoparticles. BODMEIER, R., CHEN, H., TYLE, P., and JAROSZ, P., J. Microencapsulation, 1991, 8, (2), 161–170.
  • Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods. BOGATAJ, M., MRIIAR, A., KRISTL, A., and KozJEK, F., J. Microencapsulation, 1991,8, (3), 401–406.
  • Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen. BOGGS, J. M., CHANG, N. H., and GOUNDALKAR, A., Antimicrob. Agents Chemother., 1991, 35, (5), 879–885. Encapsulated hepatocytes for controlling hyperbilirubinemia in Gunn rats. Bruni, S., and
  • CHANG, T. M., Int. .1. Artif. Organs, 1991, 14, (4), 239–241.
  • Characterization of albumin-acacia complex coacervation. BURGESS, D. J., Kwox, K. K., and MEGREMIS, P. T., J. Pharm. Pharmacol., 1991, 43, (4), 232–236.
  • Drug-oligonucleotide conjugates. BYRN, S. R., CARLSON, D. V., CHEN, J. K., CUSHMAN, M. S., GOLDMAN, M. E., MA, W. P., PIDGEON, C. L., RAY, K. A., STOWELL, J. G., and WEITH, H. L., Adv. Drug Delivery Rev., 1991, 6, (3), 287–308.
  • Ubiquinol prevents alpha-tocopherol consumption during liposome peroxidation. CABRIN I, L., STEFANELLI, C., FIORENTINI, D., and LANDI, L., Biochem. Int., 1991, 23 (4), 743–749.
  • Proton/electron stoichiometry of mitochondrial cytochrome complexes reconstituted in liposomes. Rate-dependent changes of the stoichiometry in the cytochrome c oxidase vesicles. CAPITANIO, N., CAPITANIO, G., DE-NITTO, E., VILLANI, G., and PAPA, S., FEBS Lett., 1991, 288, (1–2), 179–182.
  • Effect of nanoparticles on transdermal drug delivery. CAPPEL, M. J., and KREUTER, J., J. Microencapsulation, 1991, 8, (3), 369–374.
  • Biomimetic ion transport: pores and channels in vesicle membranes. CARMICHAEL, V. E., DUTTON, P. J., FYLES, T. M., JAMES, T. D., McKim, C., SWAN, J. A., and ZOJAJI, M., Inclusion Phenom. Mol. Recognit. (Proc. Int. Symp.), 5th, 1988, Plenum, New York, N.Y., USA, publ. 1990, pp. 145–150. Ed: J. L. Atwood.
  • An infrared spectroscopic study of specifically deuterated fatty-acyl methyl groups in phosphatidylcholine liposomes. CASTRESANA, J., VALPUES'I'A, J. M., ARRONDO, J. L. R., and GONI, F. M., Biochim. Biophys. Acta, 1991, 1065, (1), 29–34.
  • The potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia. CATTANEO, M. V., and CHANG, T. M., ASAIO Trans., 1991, 37, (2), 80–87.
  • Efficiency of liposomal ATP in cerebral ischemia: bioavailability features. CHAPAT, S., FREY, V., CLAPERON, N., BOUCHAUD, C., PUISIEUX, F., COUVREUR, P., ROSSIGNOL, P., and DELATTRE, J., Brain Res. Bull., 1991, 26, (3), 339–342.
  • Phospholipid liposomes/surfactant interactions as predictors of skin irritation. CHARAF, U. K., and HART, G. L., J. Soc. Cosmet. Chem., 1991, 42, (2), 71–85.
  • Forced convection heat transfer in microencapsulated phase change material slurries: flow in circular ducts. CHARLINYAKORN, P., SENGUPTA, S., and ROY, S. K., Int. J. Heat Mass Transfer, 1991, 34, (3), 819–833.
  • Phase I study of hepatic arterial infusion of liposome entrapped cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexaneplatinum(II)(L-NDDP). CHASE, J., WOOD, J., PAZDUR, R., KHOKHAR, A., PEREZ-SOLER, R., SIDDIK, Z. H., and RoH, M., Proc. Am. Assoc. Cancer Res. Atom. Meet., 1991, 32, 420.
  • Interaction of protein kinase C with phosphoinositides. CHACE-IAN, A., BROCKERHOFF, H., WISNIEWSKI, H. M., and CHAUHAN, V. P., Arch. Biochem. Biophys., 1991, 287, (2), 283–287.
  • Study on targeting drug delivery system: the characteristics of methotrexate microsphere and experimental treatment of hepatic tumor in rats by arterial embolization. CHEN, Q. H., Lu, W. G., GE, G. H., SHENG, Q., ZHANG, Y., XIE, X. H., WANG, Y., Wu, M. C., and ZHANG, X. H., Acta Pharm. Sin., 1991, 26, (4), 293–298.
  • Targeting drug delivery system-the characteristics of methotrexate microsphere and experimental treatment of hepatic tumor in rats by arterial embolization. CHEN, Q. H., Lu, W. G., GE, Q. H., SHENG, Q., ZHANG, Y., XIE, X. H., WANG, Y., Wu, M. C., and ZHANG, X. H., Yaoxue Xuebao, 1991, 26, (4), 293–298.
  • Study on targeting drug delivery system: the animal behavior in vivo after hepatic arterial embolization of methotrexate microsphere. CHEN, Q. H., Lu, W. G., GE, Q. H., HE, W., XIE, X. H., YANG, W. Z., and LIN, G., Acta Pharm. Sin., 1991, 26, (2), 139–143.
  • Effects of redox state for ubiquinone-10 on the membrane fluidity of cardiolipin-containing liposomes. CHENG BOH, YANG ZHENHONG, DONG YUZHI, CHENG KUNRONG, and LIN KECHUN, Bioenerg: Mot Biol. Biochem. Pathol. (Proc. Int. Symp.), 1989, Plenum, New York N.Y., USA, publ. 1990, pp. 83–88. Eds: C. H. Kim, and T. Ozawa.
  • The production and characteristics of liposomes bearing interferon antibodies on their surfaces. CHERNIAVSKII, V. A., ZIBRIN, S. V., and LEBEDEV, A. D., Zh. Mikrobiol. Epidemiol. Immunobiol., 1991, (6), 65–68.
  • Laser picosecond microspectrofluorometry of hematoporphyrin in cells and liposomes. CHERNYAEVA, E. B., VARDANYANK, A. G., KOROTEEV, N. I., KAMALOV, V. F., LOBANOV, 0. V., MIRONOV, A. F., and RUMYANZEVA, V. D., J. Photochem. Photobiol. B, Biol., 1991, 10, (3), 239-248. Characterization of distribution behavior of 2-imidazolines into multilamellar liposomes. Cnoi, Y. W., and ROGERS, J. A., J. Pharm, Sci., 1991, 80, (8), 757–770.
  • The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. CHONN, A., Cut.t.is, P. R., and DEVINE, D. V., J. Immunol., 1991, 146, (12), 4234–4241.
  • Preparation and purification of poly(isohexyl cyanoacrylate) nanocapsules. CHOUINARD, F., KAN, F. W. K., LEROUX, J. C., FOUCHER, C., and LENAERTS, V., Int. J. Pharm., 1991, 72, (3), 211–217.
  • Preparation and evaluation of cellulose acetate microcapsules of theophylline. CHOWDARY, K. P. R., and RATNA, J. V., Indian J. Pharm. Sci., 1990, 52, (6), 279–281.
  • Studies on microencapsulation by cellulose acetate. CHOWDARY, K. P. R., and RATNA, J. V., Indian Drugs, 1991, 28, (8), 361–365.
  • Dye-sensitised destabilization of liposomes bearing photo-oxidizable lipid head groups.
  • CHOWHARY, R. K., and MORGAN, C. G., Photochem. Photobiol., 1991, 53, (Suppl), 79S. Enhanced cytoplasmic delivery of liposome-encapsulated drugs. CHU CHUN JUNG, Univ.
  • California, San Francisco, CA, USA, Dissertation, 1990, 160 pp.
  • Preparation and stability of liposomes with different drugs. CHUESHOV, V. I., CHERNOV, M. Yu., SHEBANOVA, S. T., GULEVS'KII, 0. K., KORYAZOVA, L. K., and GLADUKH, E. V., Farm. Zh. (Kiev), 1991, (3), 68–71.
  • Liver and tumor uptake and plasma pharmacokinetics of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. CIVALLERI, D., EsPosuro, M., FULCO, R. A., VANNOZZI, M., BALLETTO, N., DECIAN, F., PERCIVALE, P. L., and MERLO, F., Cancer Phila., 1991, 68, (5), 988–994.
  • Kinetics of the interaction of the potential-sensitive dye Oxonol V with lipid vesicles. CLARKE, R. J., and APELL, H. J. NATO ASI Ser. Ser. C, 1990, 324 (Struct. Dyn. Equilib. Prop. Colloidal Syst.), 471–492.
  • Controlled delivery systems for proteins based on poly(lactic glycolic acid) microspheres. COHEN, S., YOSHIOKA, T., LUCARELLI, M., HWANG, L. H., and LANGER, R., Pharm. Res., 1991,8, (6), 713–720.
  • Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. COLLETTE, N., VAN DER AUWERA, P., MEUNIER, F., LAMBERT, C., SCULIER, J. P., and COUNE, A., J. Antimicrob. Chemother., 1991, 27, (4), 535–548.
  • The kinetics of uncoupled fluxes in reconstituted vesicles. CORNELIUS, F., Soc. Gen. Physiol. Ser., 1991, 46, 267–280.
  • Electrogenic pump current of sarcoplasmic reticulum calcium-ATPase reconstituted at high lipid/protein ratio. CORNELIUS, F., and MOLLER, J. V., FEBS Lett., 1991, 284, (1), 46–50. Adjuvant effect of liposomes in the autoimmune response to rat male accessory glands.
  • CORREA, S. G., and RIERA, C. M., Immunol. Lett., 1991, 28, (1), 39–46.
  • Liposomes and nanoparticles in the treatment of intracellular bacterial infections. COUVREUR, P., FATTAI., E., and ANDREMONT, A., Pharm. Res., 1991, 8, (9), 1079–1086.
  • Carotenoid absorbance changes in liposomes reconstituted with pigment-protein complexes from Rhodobacter sphaeroides. CRIELAARD, W., HELLINGWERE, K. J., and KONINGS, W. N., FEMS Symp., 1990, 53 (Mol. Biol. Membr.-Bound Complexes Phototrophic Bact.), 285–289.
  • Liposomes and immunoliposomes for controlled release or site specific delivery of anti-parasitic drugs and cytostatics. CROMMEI.IN, D. J. A., ELING, W. M. C., STEERENBERG, P. A., NASSANDER, U. K., STORM, G., DE JONG, W. H., VAN HOESEI., Q. G. C. M., and ZUIDEMA, J., J. Controlled Release, 1991, 16, (1-2), 147–154.
  • Drug targeting. CROMMELIN, D. J. A., and STORM, G., Comprehensive Medicinal Chemistry: the Rational Design, Mechanistic Study and Therapeutic Application of Chemical Design, Mechanistic Study and Therapeutic Application of Chemical Compounds, Vol. 5: Biopharmaceutics. 756 pp. Pergamon, Oxford, UK, publ. 1990, 661–702. Ed: J. B. Taylor.
  • Hydrodynamic effects on animal cells in microcarrier bioreactors. CROUGHAN, M. S., and WANG, D. I., Biotechnology, 1991, 17, 213–249.
  • Solution effects on the thermotropic phase transition of unilamellar liposomes. CROWE, L. M., and CROWE, J. H., Biochim. Biophys. Acta, 1991, 1064, (2), 267–274.
  • Further evaluation of one-point microcapsule agglutination test for diagnosis of leptospirosis. Cut, J. J., XIAO, G. X., CHEN, T. Z., ZHU, G. F., SATO, T., SEKI, M., KOBAYASHI, S., and ARIMITSU, Y., Epidemiol. Infect., 1991, 106, (3), 561–565.
  • Gradients and membrane transport in liposomal system. CuLLis, P. R., BALLY, M. B., MADDEN, T. D., MAYER, L. D., and HOPE, M. J., Trends Biotechnol., 1991, 9, (8), 268–272.
  • Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumor drug disposition. CUMMINGS, J., WILLMOTT, N., MARLEY, E., and SMYTH, J., Biochem. Pharmacol., 1991, 41, (12), 1849–1854.
  • Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine. CUOMO, V., JORI, G., RIHTER, B., KENNEY, M. E., and RODGERS, M. A., Br. J. Cancer, 1991, 64, (I), 93–95.
  • Pre-operative radiotherapy of renal cell carcinoma using intra-arterial samarium-153 activat-able glass microspheres. CURTIS, R. L., LATTIMER, J. C., EHRHARDT, G. J., DAY, D. E., VOLKERT, E. W., LANIGAN, J. P., and EVANS-BLUMER, M., J. Nucl. Med., 1991, 32, (5, Suppl.), 1089.
  • Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. CUSSENOT, 0., BERTHON, P., BERGER, R., Mowszowicz, I., FAILLE, A., HopviAN, F., TEILLAC, P., LE Duc, A., and CALVO, F., J. Urol., 1991, 14.6, (3), 881–886.
  • Large-scale preparation of asymmetrically labeled fluorescent lipid vesicles. DAO, H. N., MCINTYRE, J. C., and SLEIGHT, R. G., Anal. Biochem., 1991, 196, (1), 46–53.
  • Affinity separations using microcapsules. DAUGULIS, A. J., WIGHT, C. P., GOOSEN, M. F. A., and CIIESNEY, K. E., Sep. Biotechnol. 2 (Pap. Int. Symp.), 2nd, 1990, Elsevier, London, UK, pp. 315–324. Ed: D. L. Pyle.
  • Small unilamellar liposomes from mixed natural and polymeric phospholipids: stability and susceptibility to phospholipase A2. DAVIES, D. E., CRITCHLOW, M., GRAINGER, D. W., REICHERT, A., RINGSDORF, H., and LLOYD, J. B., Biochim. Biophys. Acta, 1991, 1084, (1), 29–34.
  • eV-RI pilus protein remains immunogenic to rabbit peyer's patch cells immunized in vitro after microencapsulation. DAVIS, D., REID, R. H., and SAU, K., Abstr. Gen. Meet. Am. Soc. Microbiol., 1991, 91, 132.
  • Permeability changes of phospholipid vesicles caused by surfactants. DE LA MAZA, A., SANCHEZ LEAL, J., PARRA, J. L., GARCIA, M. T., and RIBOSA, I., J. Am. Oil. Chem. Soc., 1991, 68, (5), 315–319.
  • Liposomal amphotericin B; a new formulation in treating disseminated cryptococcosis. DE MATOS, B., POHLE, H. D., HAHN, H., and RUE, B., Istituto Superiore di Sanita. VII International Conference on AIDS: Science Challenging AIDS; Florence, Italy, 16–21 June, 1991. 464 pp. (Vol. 1); 460 pp. (Vol. 2). Istituto Superiore di Sanita: Rome, Italy; publ. 1991, 258B.
  • Microencapsulation of drugs by pan and air suspension techniques. DEASY, P. B., Crit. Rev. Ther. Drug Carrier Syst., 1991, 8, (1), 39–89.
  • Heparin conjugated polyhydroxyethylmethacrylate microspheres for albumin separation. DENIZLI, A., KIREMITCI, M., OLCAY, M., and PEKIN, E., Arti f. Organs, 1990, 14 (Suppl. 2), 138–142.
  • Sensitization of vesicles to pH and glucose. DEVLIN, B. P., Univ. Massachusetts, Amherst, MA, USA, Dissertation, 1990, 167 pp.
  • Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry. Di Giulio, A., MAURIZI, G., ODOARDI, P., SALETTI, M. A., AMICOSANTE, G., and ORATORE, A., Int. J. Pharm., 1991, 74, (2-3), 183–188.
  • The ultraviolet derivative spectrophotometric determination of neutral liposome-entrapped beta-lactam antibiotics. Di Gun.ic), A., MAURIZI, G., SALETTI, M. A., AMICOSANTE, G., MAZZEO, P., and ORATORE, A., J. Pharm. Biomed. Anal., 1989, 7, (10), 1159–1164.
  • Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362. DINNEY, C. P., BUCANA, C. D., UTSUGI, T., FIDLER, I. J., VON ESCHENBACH, A. C., and KILLION, J. J., Cancer Res., 1991, 51, (14), 3741–3747.
  • Synergistic inhibition of spontaneous lung metastasis of murine renal adenocarcinoma (RENCA) by liposomes containing macrophage activators and IL 2. DINNEY, C. P. N., UTSUGI, T., BUCANA, C. D., FIDLER, I. J., KILLIoN, J. J., Assoc. Cancer Res. Anna. Meet., 1991, 32, 249.
  • Liver cell transplantation: improved biological response of transplanted microencapsulated hepatocytes with a liver basement membrane-like extract. DIXIT, V., ARTHUR, M., REINHARDT, R., and GITNICK, G., Gastroenterology, 1991, 100, (5, Part 2), A736.
  • Hyper-thermo chemotherapy of esophageal cancer with thermosensitive liposome, TAC- 1043. DOHMITSU, K., AKIYAMA, S., KAWASAKI, S., KATAOKA, M., KONDOH, K., YAMAUCHI, M., ITOH, K., WATANABE, T., and TAKAGI, H., Gan To Kagaku Ryoho, 1991, 18, (11), 1760–1763.
  • Quantitative determination of carboxymethyl chitin in polymer-coated liposomes. DUNG, C., and ROGERS, J. A., J. Microencapsulation, 1991, 8, (2), 153–160.
  • Structure of particles of polymeric suspensions used in immunochemical reactions. DOROKHOVA, E. A., GUSEV, S. A., GRITSKOVA, I. A., and PAPKOV, V. S., Vysokomol Soedin, Ser. B, 1991, 33, (5), 354–358.
  • Behavior of iodine-125 serum albumin microspheres in rabbits during selective injection of the agent in the renal artery. DROZDOVSKII, B. YA, ROZIEV, R. A., GONCHAROVA, A. YA, DEDENKOV, A. N., BRODSKII, R. A., and PETRIEV, V. M., Med. Radiol., 1990, 35, (11), 26–29.
  • The behavior of radioactive albumin microspheres on administration into the hepatic artery of animals. DROZDOVSKII, B. IA., ROZIEV, R. A., and GONCHAROVA, A. IA., Med. Radiol. (Mask.), 1991, 36, (7), 37–39.
  • Ibuprofen-loaded ethyl cellulose microspheres: mechanism involved in the growth of drug crystals on the particle surface. DUBERNET, C., BENOIT, J. P., and PUISIEUX, F., Eur. J. Pharm. Biopharm., 1991, 37, (1), 49–53.
  • Microencapsulation of isolated pituitary cells by polyacrylamide microlatex coagulation on agarose beads. DUPUY, B., CADIC, C., GIN, H., BAQUEY, C., Duey, B., and DUCASSOU, D., Biomaterials, 1991, 12, (5), 493–496.
  • Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. DUZGUNES, N., ASHTEKAR, D. R., FLASHER, D. L., GHORI, N., DEBS, R. J., FRIEND, D. S., and GANGADHARAM, P. R., J. Infect. Dis., 1991, 164, (1), 143–151.
  • Topical application of liposomally entrapped cyclosporin evaluated by in vitro diffusion studies with human skin. EGBARIA, K., RAMACHANDRAN, C., and WEINER, N., Skin Pharmacol., 1991, 4, (1), 21–28.
  • Spectroscopic studies of second generation sensitizers and their photochemical reactions in liposomes and cells. EHRENBERG, B., GROSS, E., LAVI, A., JOHNSON, F. M., and MALIK, Z., Proc. SPIE Int. Soc. Opt. Eng., 1991, 1426 (Proc. Opt. Methods Tumor Treat. Early Diagn.: Mech. Tech., 1991), 244–251.
  • Microspheres of human serum albumin labelled by a specific linker technology for use in radiation synovectomy. EHRHARDT, G., ZINN, K., JiA, W., DAY, D., ERBE, E., DEUTSCH, K., DEUTSCH, E., DE LA FOURNIERE, L., GRUMMON, G., and VANDERHEYDEN, J. L., J. Nucl. Med., 1991, 32, (5, Suppl.), 964.
  • Evaluation of activatable degradable glass samarium-153 microspheres for radiation synovectomy. EHRHARDT, G. J., LATTIMER, J. C., DAY, D. E., and STAPLETON, J., J. Nucl. Med., 1991, 32, (5, Suppl.), 945.
  • Cation-induced aggregation of acidic phsopholipid vesicles: the role of fatty acid unsaturation and cholesterol. EKLUND, K. K., TAKKUNEN, J. E., and KINNUNEN, P. K., Chem. Phys. Lipids, 1991, 57, (1), 59–66.
  • Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. ELDRIDGE, J. H., STAAS, J. K., MEULBROEK, J. A., TICE, T. R., and GILLEY, R. M., Infect. Immun., 1991, 59, (9), 2978–2986.
  • Controlled release of 5-fluoro-2'-deoxyuridine by the combination of prodrug and polymer matrix. ENDOH, H., KAWAGUCHI, T., SEKI, T., HASEGAWA, T., and JuNI, K., Chem. Pharm. Bull., 1991, 39, (2), 458–464.
  • A salt-activated inositol 1,3,4,5-tetrakisphosphate 3-phosphatase at the inner surface of the human erythrocyte membrane. ESTRADA-GARCIA, T., CRAXTON, A., KIRK, C. J., and MICHELL, R. H., Proc. R. Soc. Lond. (Biol), 1991, 244, (1309), 63–68.
  • Antiproliferative activity of liposome-encapsulated transforming growth factor-beta against MDA-MB-435 human breast carcinoma cells. FAN, D., PRICE, J., SCHACKERT, H., Sum, C., WILMANNS, C., CHAKRABARTY, S., and FIDLER, I. J., Cancer Commun., 1989, 1, (6), 337–343.
  • Phase I study of liposomal L MTP-PE activated autologous monocytes administered intra-cavitary in patients with pleural or peritoneal carcinomatosis. FARADJI, A., BOHBOT, A., FROST, J., SCHMITT, M., DUFOUR, P., LAI,LoT, C., BERGERAT, J. P., and OBERLING, F., Pathobiology, 1991, 59, (4), 268.
  • Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperi-toneally to patients with peritoneal carcinomatosis. FARADJI, A., BoHnoT, A., FROST, H., SCHMITT-GOGUEL, M., SIEFERT, J. C., DUFOUR, p., EBER, M., LALLOT, C., WIESEL, M. L., BERGERAT, J. P., and OBERLING, F., J. Clin. Oncol, 1991, 9, (7), 1251–1260.
  • Inhibition of phosphatidylcholine liposome oxidation by porcine plasma. FARAJI, H., and DECKER, E. A., J. Food Sc., 1991, 56, (4), 1038–1041.
  • Suppression of lipid oxidation in phosphatidylcholine liposomes and ground pork by spray-dried porcine plasma. FARAJI, H., DECKER, E. A., and AARON, D. K., J. Agric. Food Chem., 1991, 39, (7), 1288–1290.
  • Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug re.-ase and in vitro antimicrobial activity. FATTAL, E., ROJAS, J., ROBLOT-TREUPEL, L., ANDREMONT, A., and COUVREUR, P., J. Microencapsulation, 1991, 8, (1), 29–36.
  • Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. FATTAL, E., ROJAS, J YOUSSEF, M., COUVRECR, P., and ANDREMONT, A., Antimicrob. Agents Chemother., 1991, 35, (4), 770–772.
  • Transfer of retinol from retinal-binding protein complex to liposomes and across liposomal membranes. FFX, G., and JOHANNESSON, G., Methods in Enzymology, Vol. 189. Retinoids, Part A: Molecular and Metabolic Aspects. 583 pp. Academic Press, San Diego, CA, USA, publ. 1990, pp. 394–402. Ed: L. Packer.
  • Liposomal drug delivery advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. FIELDING, R. M., Clin. Pharmacokinet., 1991, 21, (3), 155–164. Rhinocerebral mucormycosis: use of liposomal amphotericin B. FISHER, E. W., TOMA, A., FISHER, P. H., and CHEESMAN, A. D., J. Laryngol. Oto/., 1991, 105, (7), 575–577.
  • Biodisposition and histological evaluation of topically applied retinoic acid in liposomal, cream and gel dosage forms. FOONG, W. C., HARSANYI, B. B., and MEZEI, M., Phospholipids: Biochem., Pharm., Anal. Consid., (Proc . Int. Colloq. Lecithin), 5th, 1989, Plenum, New York, N.Y., USA, publ. 1990, pp. 279–282. Eds: I. Hanin and G. Pepeu.
  • Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts. FRITSCHY, W. M., STRUBBE, J. H., WOLTERS, G. H. J., and VAN SCHILFGAARDE, R., Diabetologia, 1991, 34, (8), 542–547.
  • Antibody-coated liposomes as a particulate solid phase for immunoassays. Measurement of urinary 'micro-albumin'. FROST, S. J., FIRTH, G. B., and CHAKRABORTY, J., J. Immunol. Methods, 1990, 134, (2), 207–213.
  • Effect of ibuprofen on monocyte activation by liposomes containing muramyl tripeptide. FujimAKI, W., and KLEINERMAN, E. S., Assoc. Cancer Res. Annu. Meet., 1991, 32, 233.
  • Hemolysis mechanism of dental adhesive monomer (methacryloyloxydecyl dihydrogen phosphate) using a phosphatidylcholine liposome system as a model for biomembranes. FujisAwA, S., KAnoma, Y., and KOMODA, Y., Dent. Mater. J., 1990, 9, (2), 136–146.
  • Changes in NMR chemical shifts of methacrylates induced by their interactions with the phospholipid and the phospholipidicholesterol liposome system. FujtsAwA, S., KADOMA, Y., and KOMODA, Y., Dent. Mater. J., 1990, 9, (1), 100–107.
  • Liposome-entrapped calcitonin and parathyroid hormone are orally effective in rats. FUKUNAGA, M., MILLER, M. M., and DEFTOS, L. J., Horm. Metab. Res., 1991, 23, (4), 166–167.
  • In vitro study of liposome encapsulated AZT and its combination with a presumptive enzyme blocking agent (PEBA). GABEV, E. E., GABEV, E., BESHKOV, D., and ARGIROVA, R., Istituto Superiore di Sanita. VII International Conference on AIDS: Science Challenging AIDS; Florence, Italy, 16–21 June 1991. 464 pp. (Vol. 1); 460 pp. (Vol. 2). Istituto Superiore di Sanita: Rome, Italy; publ. 1991, 92B.
  • Selective tumor localization of doxorubicin encapsulated in long-circulating stealth lipo-somes (S-DOX). GABIZON, A., Assoc. Cancer Res. Annu. Meet., 1991, 32, 382.
  • Low-density lipoproteins interact with liposome-binding sites on the cell surface. GALKINA, S.
  • I., IvANov, V. V., PREOBRAZHENSKY, S. N., MARGOLIS, L. B., and BERGELSON, L. D., FEBS Lett., 1991, 287, (1-2), 19–22.
  • Tumoricidal activity of cancer patients' monocytes after in vivo treatment with liposomes containing muramyl tripeptide. GALL IGIO N I, E., QUA IA, M., SPADA, A., FAVARO, D., SIMONELLA, S., FRESCHI, A., SANTAROSA, M., MAIO, M., ALBERT, G., and MONFARDINI, S., Assoc. Cancer Res. Annu. Meet., 1991, 32, 234.
  • Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone preparation morphology and release properties. GANGRADE, N., and PRICE, J. C., J. Microencapsulation, 1991, 8, (2), 185–202.
  • Mechanism of action of the peptide antibiotic nisin in liposomes and cytochrome c oxidase-containing proteoliposomes. GAO, F. H., ABEE, T., and KONINGS, W. N., App/. Environ. Microbiol., 1991, 57, (8), 2164–2170.
  • Phagocytosis of protein coated colloidal-gold-agarose-gelatin microbeads by cultured uterine glandular epithelial and stromal cells. GAO, K. X., SMITH, S. E., and GODKIN, J. D., Biotech. Histochem., 1991, 1, (1), 1–6.
  • A novel cationic liposome reagent for efficient transfection of mammalian cells. GAO, X. A., and HUANG, L., Biochem. Biophys. Res. Commun., 1991, 179, (1), 280–285.
  • Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens. GARCON, N. M. J., and Slx, H. R., J. Immunol., 1991, 146, (11), 3697–3702.
  • Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: effect of the phospholipid composition. GARNIER, F., FORQUET, F., BEtrrouNo, P., and GERLIER, D., Vaccine, 1991, 9, (5), 340–345.
  • Effect of kampo medicines on lipid peroxidation phosphatidylcholine liposomes. GERGEL, D., and MISIK, V., Pharmazie, 1991, 46, (6), 469–470.
  • Interfacial catalysis by phospholipase A2: substrate specificity in vesicles. GHOMASHCHI, F., Yu
  • BAO ZHU, BERG, 0., JAIN, M. K., and GELB, M. H., Biochemistry, 1991, 30, (29), 7318–7329. Oral vaccines: design and delivery. GILLIGAN, C. A., and Po, A. L. W., Int. J. Pharm., 1991, 75, (I), 1-24.
  • Insulin-carrying microspheres in vitro studies. GIZURARSON, S., and BECHGAARD, E., Chem. Pharm. Bull., 1991, 39, (7), 1892–1893.
  • In vivo oximetry using a nitroxide-liposome system. GLOCKNER, J. F., CHAN, H. C., and SWARTZ, H. M., Magn. Reson. Med., 1991, 20, (1), 123–133.
  • Fusion of artificial lipid membranes induced by a synthetic fusion peptide of arenaviruses.
  • GLUSHAKOVA, S. E., OMECYANENKO, V. G., LUKASHEVICH, I. S., BOGDANOV, A. A. JR, MOSHNIKOVA, A. B., KOZHICH, A. T., and ToRmin.IN, V. P., Biokhimiya, 1991, 56,(4), 579–588. Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. GOI.DBERG, J. A., THOMSON, J. A., BRADNAM, M. S., FENNER, J., BESSENT, R. G., McKiLL0P, J. H., KERR, D. J., and MCARDLE, C. S., Br. J. Cancer, 1991, 64, (1), 114–119.
  • Synthesis of ceramic nanoparticles by the ultrasonic injection of an organosilazane precursor. GONSALVES, K. E., STRUTT, P. R., and XIAO, T. D.„4dv. Mater (Weinheirn), 1991,3, (4), 202–204.
  • Liposomes and pulmonary alveolar macrophages: functional and morphologic interactions. GONZALEZ-ROTIII, R. J., STRAUB, L., CACACE, J. L., and SCHREIER, H., Exp. Lung. Res., 1991, 17, (4), 687–706.
  • Fluorescent investigation of methemoglobin structural changes upon interaction with liposomes. GORBENKO, G. P., and DREVAL, V. I., Biofizika, 1990, 35, (6), 925–927.
  • Effect of reticuloendothelial blockade on tissue distribution of 99mTc-labeled synthetic liposomes in Ehrlich solid tumor-bearing mice. GOTO, R., KUBO, H., and OKADA, S., Chem. Pharm. Bull., 1991, 39, ( 1), 230–232.
  • Cell specific liposomes as modified with saccharide determinants. GOTOH, M., and SUNAMOTO, J., Yukagaku, 1991, 40, (5), 384–391.
  • Effect of dilauroylphosphatidylcholine liposomes on motility, induction of the acrosome reaction, and subsequent egg penetration of ram epididymal sperm. GRAHAM, J. K., NOLAN, J. P., and HAMMERSTEDT, R. H., Biol. Reprod., 1991, 44, (6), 1092–1099.
  • Synthetic peptides corresponding to human follicle-stimulating hormone (hFSH)-beta-(1-15) and hFSH-beta-(51-65) induce uptake of calcium-45(2 +) by liposomes: evidence for calcium-conducting transmembrane channel formation. GRASSO, P., SANTA COLOMA, T. A., and REICHERT, L. E. JR., Endocrinology, 1991, 128, (6), 2745–2751.
  • Liposomes and cancer therapy. GREGORIADIS, G., and FLORENCE, A. T., Cancer Cells, 1991, 3, (4), 144–146.
  • Biological behavior of liposomes. GREGORIADIS, G., Phospholipids: Biochem. Pharm. Anal. Consid. (Proc. Int. Colloq. Lecithin), 5th, 1989, Plenum, New York, N.Y., USA, publ. 1990, pp. 123–132. Eds: I. Hanin and G. Pepeu.
  • Nonaqueous liquid filled microcapsules. GRINSTAFF, M. W., and Susimx, S., Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.), 1991, 32, (1), 255–256.
  • Spectroscopic studies of 9,10 -dimethylanthracene and bacteriorhodopsin: photosensitization by porphyrins in liposomes. GROSS, E., EHRENBERG, B., and JOHNSON, F. M., Photochem. Photobiol., 1991, 53, (Suppl.), 14S.
  • Amphotericin B colloidal dispersion (ABCD), a safe amphotericin B dosage form. Guo, L. S. S., CHOU, E., NAJAFI, A., PORTER, J., and FIELDING, R. M., Abstr. Gen. Meet. Am. Soc. Microbial, 1991, 91, 13.
  • Lung targeting through liposomes. GUPTA, V. B., JAIN, N. K., VYAS, S. P., and GOGOI, P. J., Indian Drugs, 1991, 28, (9), 393–397.
  • Photostabilization of riboflavin by incorporation into liposomes. HABIB, M. J., and ASKER, A. F., J. Parenter. Sci. Technol., 1991, 45, (3), 124–127.
  • Liposomes as carriers of radioactive rhenium-complex. HAFELI, U., TIEFENAUER, L., SCHUBIGER, P. A.,, and WEDER, H. G., Technetium, and Rhenium in Chemistry and Nuclear Medicine 3; Third International Symposium on Technetium and Rhenium in Chemistry and Nuclear Medicine, Padua, Italy, 6–8 September, 1989, 801 pp. Cortina International: Verona, Italy; publ. 1990, pp. 643–646 Eds: M. Nicolini, G. Bandoli and U. Mazzi.
  • A lipophilic complex with a ratio of rhenium-186 and rhenium-188 incorporated in liposomes suitable for radiotherapy. HAFELI, U., TIEFENAUER, L. X., SCHUBIGER, P. A., and WEDER, H. G., Nucl. Med. Biol. 1991, 18, (5), 449–454.
  • Small lipid particles dispersed in aqueous medium. HANDA, T., Pharm. Tech. Jpn., 1991, 7, (5), 592–597.
  • Application of lipid derivatives (liposomes) to the drug delivery system. Part 8. HARA, K., Yushi, 1991, 44, (4), 83–87.
  • Use of lipids (liposomes) in drug delivery systems. Part 6. HARA, K., Yushi, 1991, 44, (2), 84-88. Generation of recombinant baculovirus via liposome-mediated transfection. HARTIG, P. C., CARBON, M. C., and KAWANISHI, C. Y., Biotechniques, 1991, 11, (3), 312–313.
  • Encapsulation of doxorubicin into liposomes by a freeze-thawing method using buffer solution. HAYAKAWA, E., NAKAKURA, M., KATO, Y., OKUBO, Y., and HOSOKAWA, T., Chem. Pharm. Bull., 1991, 39, (3), 773–776.
  • Thermal adaptation in biological membranes: functional significance of changes in phospholipid molecular species composition. HAZEI., J. R., WILLIAMS, E. E., LIVERMORE, R., and MOZINGO, N., Lipids, 1991, 26, (4), 277–282.
  • Calcium phosphate-induced fusion of human erythrocyte ghosts monitored by dilution of a membrane bound fluorescence probe. HERRMANN, A., and HILLEBRECHT, B., Biomed. Biochim. Acta, 1991, 50, (3), 251–256.
  • Enzyme, toxin, liposome-disrupting and hemolytic activities of adenylate cyclase toxin from Bordetella pertussis. HEWLETT, E. L., EHRMANN, I. E., GRAY, M. C., YOUNG, W. W. JR, and
  • GORDON, V. M., Zentralbl. Bakteriol. Suppl., 1990, 19, (Bact. Protein Toxins), 249–254.
  • Factors influencing the profiles of TRH release from copoly(dl-lacticiglycolic acid) micro-spheres. HEYA, T., OKADA, H., OGAWA, Y., and TOGUCHt, H., Int. J. Pharm., 1991, 72, (3), 199–205.
  • Comparative electrophysiological study of reconstituted giant vesicle preparations of the rabbit skeletal muscle sarcoplasmic reticulum potassium ion channel. HIRASHIMA, N., IstuaAstu, H., and KIRINO, Y., Biochim. Biophys. Acta, 1991, 1067, (2), 235–240.
  • Distribution of liposome-incorporated carboxyfluorescein in rabbit eyes. HIRNLE, E., HIRNLE, P., and WRIGHT, J. K., J. Microencapsulation, 1991, 8, (3), 391–400.
  • Drug depots in lymph nodes: Which carrier is most appropriate? HIRNLE, P., J. Microencapsul-ation, 1991,8, (1), 103–119.
  • Histological findings in rabbit lymph nodes after endolymphatic injection of liposomes containing blue dye. HIRNLE, P., J. Pharm. Pharmacol., 1991, 43, (4), 217–218.
  • Liposomes containing blue dye for preoperative lymph node staining: distribution and stability in dogs after endolymphatic injection. HIRNLE, P., and SCHUBERT, R., Int. J. Pharm., 1991, 72, (3), 259–269.
  • Immunotherapy of murine visceral leishmaniasis with murine recombinant interferon-gamma. and MTP-PE encapsulated in liposomes. HOCKERTZ, S., FRANKE, G., PAULINI, I., LOHMANN-MATTHES, M. L., J. Interferon. Res., 1991, 11, (3), 177–185.
  • Relationship of arterial wall uptake of racliolabeled liposomes to the presence of monocyteimacrophage cells in the hypertensive and atherosclerotic arterial wall. HODIS, H. N., AMARTEY, J. K., CRAWFORD, D. W., WICKHAM, E., SHARMA, R. C., and BLANKENHORN, D. H., Atherosclerosis, 1991, 87, (2-3), 109–117.
  • Photosensitized production of singlet oxygen by merocyanine 540 bound to liposomes. HOEBEKE, M., PIETTE, J., and VAN DE VORST, A., J. Photochem. Photobiol., B, 1991, 9, (3-4), 281–294.
  • Measurement of bromsulfalein retention in the mouse as a possible parameter for assessment of liver function after administration of liposomal preparations. HOFFMANN, J., FICHTNER, I., BECKER, M., and LEMM, M., Pharmazie, 1991, 46, (3), 222–223.
  • Pigmented polymer particles with controlled surface properties. HOU-WEI-HSIN, LLOYD, T. B., and FOWKES, F. M., Polym. Mater. Sci. Eng., 1991, 64, 353–354.
  • Hydrophobic modification of water soluble drug and its reconstitutable liposomes. Hou, X. P., Cul, D. H., Yi, Y. Y., Li, X. Y., and YANG, L. P., Yao Hsueh Hsueh Pao, 1990, 25, (11), 854–858.
  • The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker. HUBERT, B., ATKINSON, J., GUERRET, M., HOFFMAN, M., DEVISSAGUET, J. P., and MAINCENT, P., Pharm. Res., 1991, 8, (6), 734–738.
  • Liposomes for the transformation of eukaryotic cells. HUG, P., and SLEIGHT, R. G., Biochim. Biophys. Acta, 1991, 1097, (1), 1–17.
  • Synthesis and characterization of digoxin-phospholipid conjugates. HWANG, D. R., SCOTT, M. E., and HEDAYA, E., Bioconjug. Chem., 1990, 1, (5), 309–313.
  • The in vivo distribution of the 99mTc-labelled albumin and gelatin microspheres of a tuberculostatic agent, rifampicin. ICSERI, E., ERCAN, M. T., KACS, H. S., and HINCAL, A. A., Boll. Chim. Farm. 1991, 130, (2), 66–70.
  • Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia. IGA, K., HAMAGUCHI, N., IGARI, Y., OGAWA, Y., GOTOH, K., OOTSU, K., TOGUCHI, H., and SHIMAMOTO, T., J. Pharmacol. Exp. Ther., 1991, 257, (3), 1203-1207.
  • Increased tumor cisplatin levels in heated tumors in mice after administration of thermosen-sitive, large unilamellar vesicles encapsulating cisplatin. I GA, K., HAMAGUCHI, N., IGARI, Y., OGAWA, Y., TOGUCHI, H., and SHIMAMOTO, T., J. Pharm. Sci., 1991, 80, (6), 522–525.
  • Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria. INDIVERI, C., TONAZZI, A., PREZIOSO, 0., and PALMIERI, F., Biochim. Biophys. Acta, 1991, 1065, (2), 231–238.
  • Effect of dibucaine on the association of protein kinase C with liposome. IRITA, K., Masui, 1991, 40, (4), 594–598.
  • Interaction of recombinant human interferon-gamma with liposomes. I sui IHARA, H., HARA, T., ARAMAKI, Y., TSUCHIYA, S., and Hosoi, K., Chem. Pharm. Bull., 1991, 39, (6), 1536–1539.
  • Identification by proteoliposome binding assay of type-selective herpes simplex virus-binding polypeptides in solubilized cellular plasma membrane. ISO NO, T., and SET°, A., Med. Sci. Res., 1990, 18, (20), 807–808.
  • Microencapsulated iron for food fortification. JACKSON, L. S., and LEE, K., J. Food Sci., 1991, 56, (4), 1047-1050.
  • Microencapsulation and the food industry. JACKSON, L. S., and LEE, K., Lebensm. Wiss. Technol., 1991, 24, (4), 289–297.
  • Repair of the blood-brain barrier following implantation of polymer capsules. JAEGER, C. B., WINN, S. R., TRESCO, P. A., and AEBISCHER, P., Brain Res., 1991, 551, (1–2), 163–170. Phospholipase A2-catalyzed hydrolysis of vesicles: uses of interfacial catalysis in the scooting mode. JAIN, M. K., and GELB, M. II., Methods Enzymol., 1991, 197, 112–125.
  • Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. JANt, P., HALBERT, G. W., LANGRIDGE, J., and FLORENCE, A. T., J. Pharm. Pharmacol., 1990, 42, (12), 821–826.
  • Studies of sea buckthorn seed oil and sea buckthorn seed oil fortified with sodium selenite in vivo on sodium potassium atpase activity in erythrocyte ghosts in rats. Ji, Y., and GAO, Y., Acta Nutr. Sin., 1991, 13, (1), 20–24.
  • Specific enzyme-induced decapsulation of drugs. JOHNSTON, D. E. JR, Emory Univ., Atlanta, GA, USA, Dissertation, 1990.
  • The effect of blood serum on the size and stability of phospholipid liposomes. JONES, M. N., and NICHOLAS, A. R., Biochim. Biophys. Acta, 1991, 1065, (2), 145–152.
  • Lung uptake of liposome-entrapped glutathione after intratracheal administration. JURIMA-ROMET, M., and SHEK, P. N., J. Pharm. Pharmacol., 1991, 43, (1), 6–10.
  • Perfume-loaded liposomes. JUSZYNSKI, M., AZOURY, R., and RAFAEI.OFF, R., Seifen, Oele, Fette, Wachse, 1991, 117, (7), 259–262.
  • Gadolinium-labeled liposomes containing various amphiphilic gadolinium-DTPA deriva-tives: targeted MRI contrast enhancement agents for the liver. KABALKA, G. W., DAVIS, M. A., Moss, T. H., BUONOCORE, E., HUBNER, K., HOLMBERG, E., MARUYAMA, K., and HUANG, L., Magn. Reson. Med., 1991, 19, (2), 406–415.
  • Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver. KABALKA, G. W., DAVIS, M. A., HOLMBERG, E., MARUYAMA, K., and fluANG, L., Magn. Reson. Imaging, 1991,9, (3), 373–377.
  • A simple spectroscopic method for studying erythrocyte ghost resealing. KAHANA, E., STREICHMAN, S., and SILVER, B. L., Biochim. Biophys. Acta, 1991, 1066, (1), 6–8.
  • New biofunctionality materials based on structure, mechanism, and function of elastic fiber matrix. II. Development of biomaterials corresponding to coacervate characteristics. KAIBARA, K., MIYAKAWA, K., OKAMOTO, K., UEMURA, Y., and KONDO, M., Kobunshi Ronbunshu, 1991, 48, (5), 311–317.
  • Application and development of liposomes to cosmetics. KAKOKI, H NISHIYAMA, S., and YAMAGUCHI, M., Fragrance J ., 1991, 19, (3), 49–55.
  • Antitumor activity of liposome-encapsulated cortifen administered to mice with solid tumors. KAI.EDIN, V. I., and KURUNOV, Yu N., Eksp. Onkol., 1991, 13, (2), 65–67.
  • Preparation and characterization of immunoliposomes for targeting of antiviral agents. KALVAKOLANU, D. V. R., and ABRAHAM, A., Biotechniques, 1991, 11, (2), 218–220. 222, 224–225.
  • Comparison of the cardiotoxic effects of liposomal doxorubicin TLC- D99 vs. free doxorubicin in beagle dogs. KANTER, P. M., PILKIEWICZ, F. G., PAVELIC, Z., and MAYER, L., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 381.
  • Reconstitution of tonoplast hydrogen ion-ATPase from mung bean (Vigna radiata L.) hypo-cotyls in liposomes. KASAMO, K., YAMANISHI, II., KAGITA, F., and SAJI, H., Plant Cell Physiol., 1991, 32, (5), 643–651.
  • Proliposomes on indomethacin for oral administration. KATARE, O. P., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (1), 1–7.
  • Preparation and performance evaluation of plain proliposomal systems for cytoprotection. KATARE, O. P., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (3), 295–300.
  • Hydrogel microspheres. II. Precipitation copolymerization of acrylamide with comonomers to prepare monodisperse hydrogel microspheres. KAWAGUCHI, II., YAMADA, Y., KATAOKA, S., MORITA, Y., and OHTSUKA, Y., Polym. J., 1991, 23, (8), 955–962.
  • Development of 111In labeled activated carbon microspheres for analysis of mammary lymph flow by double isotope method: preliminary report. KAWANISIII, T., KARAKI, Y., MAEDA, M., SAEKI, T., FujIMAKI, M., SETO, H., and HONDA, '1'., Nippon Geka Gakkai Zasshi, 1991,92, (4), 474.
  • Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin contain-ing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). KAWASHIMA, Y., NIWA, T., TAKEUCH I, H., HINo, T., and 1To, Y., J. Controlled Release, 1991, 16, (3), 279–289.
  • Studies of peptides forming 3(10)- and alpha-helices and beta-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy. KENNEDY, D. F., CRISMA, M., TONIOLO, C., and CHAPMAN, D., Biochemistry, 1991, 30, (26), 6541–6548.
  • Incorporation and activation of a membrane-bound enzyme in bilayers of liposomes. KHEIROLOMOOM, A., MIYAZATO, K., KATOH, S., and SADA, E., Appl. Microbiol. Biotechnol., 1991, 35, (4), 521–524.
  • Reaction characteristics and stability of a membrane-bound enzyme reconstituted in bilayers of liposomes. KHEIROLOMOOM, A., KATOH, S., SADA, E., and YOSHIDA, K., Biotechnol. Bioeng., 1991, 37, (9), 809–813.
  • Development of liposomes-encapsulated lipophilic cisplatin analogs. KHOKFIAR, A. R., AL-BAKER, S., KRAKOFF, I. H., and PEREZ-SOLER, R., Proc. Am. Assoc. Cancer Res. Annu., Meet., 1991, 32, 409.
  • Interaction of poly(1.-lysine-alt-terephthalic acid) microcapsules with fibrinogen. KIDOKORO, M., OHSHIMA, H., and KONDO, T., J. Microencapsulation, 1991, 8, (1), 63–70.
  • Possibility of heat sterilization of liposomes. KIKUCHI, II., CARLSSON, A., YACHI, K., and HIROTA, S., Chem. Pharm. Bull., 1991, 39, (4), 1018–1022.
  • A spray-drying method for mass production of liposomes. KIKUCHI, H., YAMAUCHI, H., and HiRoTA, S., Chem. Pharm. Bull., 1991, 39, (6), 1522–1527.
  • Hematin- and peroxide-catalyzed peroxidation of phospholipid liposomes. KIM, E. H., and SEVANIAN, A., Arch. Biochem. Biophys., 1991, 288, (2), 324–330.
  • Delivery of phytochrome into plant protoplasts by liposomes. KIM- IN-Soo, Lim-MYLING-H(), and SONG-PILL-SOON., Han'guk Saenghwa Hakhoechi, 1991, 24, (2), 103–110.
  • Slow release of microencapsulated model compounds on insect pheromone using low molecular weight polyethylene and urea formaldehyde resin. Km, J. H., OH, W. T., and Km, Y. J., J. Korean Agric. Chem. Soc., 1991, 34, (2), 110–116.
  • Development and application of microcapsules in cosmetics and toiletries. Development of fragrance microcapsules for controlled release. KINOSHITA, M., and KIYAMA, K., Fragrance J., 1991, 19, (3), 33–38. 48.
  • Photodegradable polymer microcapsules. KITANO, H., OEHMICHEN, T., and IsE, N., Makromol. Chem., 1991, 192, (5), 1107–1114.
  • Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. KLIBANOV, A. L., MARUYAMA, K., BECKERLEG, A. M., TORCHILIN, V. P., and HUANG, L., Biochim. Biophys. Acta, 1991, 1062, (2), 142–148.
  • Interactions of a cytolytic toxin from Bacillus thuringiensis var. israelensis with liposomes and membranes. KNOWLES, B. H., CARROLL, J. G., HORSNELL, J. M., and ELLAR, D. J., Zentralbl. Bakteriol. Suppl., 1990, 19 (Bact. Protein Toxins), 207–208.
  • Effects of vitamin K provision and pelentan injections on the sodium, potassium and spectrin-dependent ATPases of rat erythrocyte ghosts. KODENTSOVA, V. M., SOKOCNIKOV, A. A., VRZHESINSKAYA, 0. A., and SPIRR7HEV, V. B., Biokhimiya, 1991, 56, (4), 727–732.
  • Anthrax toxin protective antigen: low-pH-induced hydrophobicity and channel formation in liposomes. KOEHLER, T. M., and COLLIER, R. J Mol. Microbiol., 1991, 5, (6), 1501–1506.
  • Role of oxygen species and lipid peroxidation for anti-tumor effect of intra-arterial injection with degradable starch microspheres. KOKURA, S., YOSHIKAWA, T., TAKAHASHI, S., °YAMADA, H., SUGINO, S., and KONDO, M., Gan To Kagaku Ryoho, 1991, 18, (11), 1947–1950.
  • A new experimental animal model of portal hypertension. Intrahepatic portal obstruction by injecting DEAE-cross-linked dextran microspheres into the portal vein in the rabbit. KOMEICHI, H., KATSUTA, Y., ARAMAKI, T., and OKUMURA, H., Nippon Ika Dazgaku Zasshi, 1991, 58, (3), 273–284.
  • Chemoembolization with degradable starch microspheres for liver metastases of colorectal cancer. KONDO, M., ITANI, K., YOSHIKAWA, T., OYAMADA, H., ICHIKAWA, H., KOKURA, S., TAINAKA, K., and SUGINO, S., Gan to Kagaku Ryoho, 1991, 18, (4), 535–540.
  • Characteristics of microcapsule membranes as viewed from a standpoint of membrane science. KONDO, T., Membrane, 1991, 16, (3), 169–177.
  • Inhibition of growth of rat hepatoma by local injection of liposomes containing recombinant interleukin-2. Antitumor effect of IL-2 liposome. KONNO, H., YAMASHITA, A., TADAKUMA, T., and SAKAGUCHI, S., Biotherapy, 1991, 3, (3), 211–218.
  • Autologous transplantation of an immunomagnetic bead purged marrow in patients with relapsed acute lymphoblastic leukemia. KORBLING, M., KNALIF, W., FUNDERUD, S., KVALHEIM, G., and HuNsTEIN, W., Haematologica, 1991, 76, (Suppl. 1), 29–36.
  • Photooxidation of cholesterol in liposomal membranes and homogeneous solution relative rates of formation of singlet oxygen adducts. KORYTOWSKI, W., BACHOWSKI, G. J., and GIROTTI, A. W., Photochem. Photobiol., 1991, 53, (Suppl.), 119S.
  • Peroral administration of nanoparticles. KREUTER, J., Adv. Drug Delivery Rev., 1991, 7, (1), 71–86. Liposomes and nanoparticles as vehicles for antibiotics. KREUTER, J., Infection, 1991, 19, (Suppl. 4), S224–S228.
  • Nanoparticle-based drug delivery systems. KREUTER, J., J. Controlled Release, 1991, 16, (1-2), 169–176.
  • Effect of T4N5 liposome-enhanced DNA repair on UV-induced immune suppression in the mouse. KRIPKE, M. L., Cox, P., and YAROSH, D. B., Photochem. Photobiol, 1991, 53, (Suppl.), 29S.
  • Preparation and evaluation of ethyl cellulose microcapsules with bacampicillin. KRISTL, A., BOGATAJ, M., MAHAR, A., and KozjEK, F., Drug Dev. Ind. Pharm., 1991, 17, (8), 1109–1130.
  • Automated assays of liposome immunolysis for phenytoin phenobarbital and carbamazepine. KUBOTSU, K., GOTO, S., FUJITA, M., TUCHIYA, H., KIDA, M., TAKANO, S., MATSUURA, S., and SAKLTRABAYASHI, I., Clin. Chem., 1991, 37, (6), 1015.
  • Disposition of lypophili zed (methylmethacrylate-14c, 2-hydroxyethylmethacrylate, butylacrylate) nanoparticles in rats and their effect on zoxazolamine paralysis time. KUKAN, M., KOPRDA, V., BEZEK, S., KALAL, J., LABSKY, J., and TRNOVEC, T., Pharmazie, 1991, 46, (1), 37–39.
  • The effects of macrolide antibiotics on the membranes of DPPC liposome bilayer rat erythrocytes and hepatocytes. KURATO, T., NISHIMURA, Y., Tsuji, M., KoBAYASHI, S., OGUCHI, K., HOSOYAMADA, A., and YASUHARA, H., Jpn. J. Pharmacol., 1991, 55, (Suppl. 1), 202 pp.
  • Suppressive effect of liposome-entrapped phenytoin on status epilepticus in rats. KUROKOUCH I, A., Fukushima Igaku Zasshi, 1990, 40, (3), 419–432.
  • Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique. KWOK, K. K., GROVES, M. J., and BURGESS, D. J., Pharm. Res., 1991, 8, (3), 341–344.
  • A study of the zeta potential of microcapsules during ageing. LABHASETWAR, V. D., and DORLE, A. K., J. Microencapsulation, 1991, 8, (1), 83–85.
  • Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy. LABIB, A., LENAERTS, V., CHOUINARD, F., LEROUX, J. C., OUELLET, R., and VAN-LIER, J. E., Pharm. Res., 1991, 8, (8), 1027–1031.
  • Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa. LAGACE, J., DUBREUIL, M., and MONTPLAISIR, S., J. Microencapsulation, 1991, 8, (1), 53–61.
  • Drug targeting using non-magnetic and magnetic albumin-globulin mix microspheres of mefenamic acid. LALLA, J. K., and AH6JA, P. L., J. Microencapsulation, 1991, 8, (1), 37–52.
  • Kinetics of HIV-1 fusion with liposomes and erythrocyte ghosts. LARSEN, C. E., NIR, S., ALFORD, D. R., JENNINGS, M., LEE, K. D., and DUZGUNES, N., Istituto Superiore di Sanita. VII International Conference on AIDS: Science Challenging AIDS; Florence, Italy, 16–21 June, 1991. 464 pp. (Vol. 1); 460 pp. (Vol. 2). Istituto Superiore di Sanita: Rome, Italy; publ. 1991, p. 97.
  • Cotton Gossypium Hirsutum L. Stoneville 825 tobacco budworm TRW Heliothis virescens F: evaluation of microencapsulated curacron for controlling tobacco budworm 1990. LATHEEF, M. A., Insecticide and Acaricide Tests, Vol. 16. 327 pp. Entomological Society of America: Lanham, Maryland, USA, 1991, p. 187 Ed: J. H. Thomas.
  • Release of methotrexate from microsphere-in-oil-in-water emulsions. LAW, S. L., and LIN, F. M., Drug. Dev. Ind. Pharm., 1991, 17, (7), 919–930.
  • Efficacy and safety of ambisome liposomal amphotericin B in primary episodes of crypto-coccosis in patients with HIV infection. LAZAR, J. T., and KsIONSKI, G. E., Istituto Superiore di Sanita. VII International Conference on AIDS: Science Challenging AIDS; Florence, Italy, 16–21 June, 1991. 464 pp. (Vol. 1); 460 pp. (Vol. 2). Istituto Superiore di Sanita: Rome, Italy. publ. 1991, p. 226B.
  • Liposome. LEE-OK-SUP, Hwahak Kwa Kongup Ui Chinbo, 1989, 29, (5), 298–304.
  • Mixed-walled microcapsules made of cross-linked proteins and polysaccharides: preparation and properties. LEVY, M. C., and ANDRY, M. C., J. Microencapsulation, 1991, 8, (3), 335–348.
  • Fourier transform infrared spectroscopic studies of human serum albumin microcapsules prepared by interfacial crosslinking with terephthaloyl chloride: influence of poly-condensation pH on spectra and relation with microcapsule morphology and size. LEVY, M. C., LEFEBVRE, S., RAHMOUNI, M., ANDRY, M. C., and MANFAIT, M., J. Pharm. Sci., 1991, 80, (6), 578–585.
  • Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders. Li, F., and PESTRONK, A., J. Neural. Sci., 1991, 104, (2), 209–214.
  • Fluorescence aspects of the binding of HPD to liposomes. Li-Lu, and YAN-XUEMING, Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1990, 22, (6), 557–562.
  • Effects of liposomes made of purified lecithins on the growth of tumor cells in vitro and in vivo. Li, Z., TIAN, E., HE, J., ARDALAN, B., and USIA, S. L., Proc. Am, Assoc. Cancer Res. Meet., 1991, 32, 432.
  • Encapsulation of drugs into large unilamellar liposomes prepared by an extemporaneous method. LIAUTARD, J., PHILIPPOT, J. R., and LIAUTARD, J. P., J. Microencapsulation, 1991,8, (3), 381–390.
  • Trace organic analysis of microencapsulated materials. LIEBMAN, S. A., SNYDER, A. P., REUTTER, D. J., WASSERMAN, M. B., and SCHIFF, L. J., Report, 1989, (GC-TR-89-1728-001, CRDEC-CR-051; Order No. AD-A216847), 107 pp.
  • Developing the technology for the production of radiocontrast microspheres used for the diagnosis of small-intestine stenoses. LIKHODED, V. A., PLECILEV, V. V., KORNILAEV, P. G., LUK-YANOVA, N. B., and DAVLETSHINA, R. YA, Farmatsiya (Mose.), 1991, 40, (2), 65–66.
  • Enhanced biliary iron excretion using amphiphilic liposomal PE-DTPA. LIN, E., GRANT, C., and ADAMS, P. C., Gastroenterology, 1991, 100, (5, Part 2), A767.
  • Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate. I. Formation condition and micromeritic properties. LIN, S. Y., TZAN, Y. L., LEE, C. J., and WENG, C. N., J. Microencapsulation, 1991, 8, (3), 317–326.
  • Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules. LIN, S. Y., and KAO, Y. I-I., Pharm. Res., 1991, 8, (7), 919–924.
  • Critical behavior of vesicles and membranes. LIPOWSKY, R., Collog. Phys. (C7, Int. Workshop Geom. Interfaces, 1990), 1990, C7-243-C7–248.
  • Large liposomes containing ganglioside GM I accumulate effectively in spleen. Liu, D., MORI, A., and HUANG, L., Biochim. Biophys. Acta, 1991, 1066, (2), 159–165.
  • Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats. LONGUET, P., Joi.y, V., AMIRAULT, P., SETA, N., CARBON, C., and YEN1, P., Antimicrob. Agents Chemother., 1991, 35, (7), 1303–1308.
  • Improvement of ocular penetration of amikacin sulfate by association to poly(butylcyanoacrylate) nanoparticles. LOSA, C., CALVO, P., CASTRO, E., VILA-JATO, J. L., and ALONSO, M. J., J. Pharm. Pharmacol., 1991, 43, (8), 548–552.
  • A polymer carrier system for taste masking of macrolide antibiotics. Lu, M. Y., BORODKIN, S., WOODWARD, L., Li, P., DIESNER, C., HERNANDEZ, L., and VADNERE, M., Pharm. Res., 1991,8, (6), 706–712.
  • Signal-sensitive release of contents from liposomes bearing surface-grafted polyelectrolyte chains. MAEDA, M., KUMANO, A., and TIRRELL, D. A., Ann. NY Acad. Sci., 1991, 618 (Temporal Control Drug Delivery), 362–366.
  • Unusual product ratios resulting from the gamma-irradiation of cholesterol in liposomes. MAERKER, G., and JONES, K. C., Lipids, 1991, 26, (2), 139–144.
  • An ultrarapid filtration method adapted to the measurements of water and solute permeability of synthetic and biological vesicles. MARTIAL, S., and RIPOCHE, P., Anal. Biochem., 1991, 197, (2), 296–304.
  • Effect of molecular weight in amphipathic polyethylene glycol on prolonging the circulation time of large unilamellar liposomes. MARUYAMA, K., YUDA, T., OKAMOTO, A., ISHIKURA, C., KOJIMA, S., and IWATSURU, M., Chem. Pharm. Bull., 1991, 39, (6), 1620–1622.
  • Cationic liposomes enable bovine herpesvirus type 2 DNA to infect cells. Acta Virol., (Engl. edn), 1991, 35, (1), 107.
  • A comparative study of the bronchodilator effect and duration of action of liposome encapsulated beta-2 adrenergic agonists in the guinea-pig. MCCALDEN, T. A., and RADHAKRISHNAN, R., Pulm. Pharmacol., 1991, 4, (3), 140–145.
  • Enteric administration of Af-121 phi in microspheres prevents disease after challenge with diarrhea-producing Escherichia coli RDEC-1. MCQUEEN, C., BOEDEKER, E., GOMEZ, J., FLEMING, E., REID, R., WOLF, M., LE, M., and BROWN, W., Gastroenterology, 1991, 100, (5, Part 2), A599.
  • Mechanisms of candidacidal action of liposomal-amphotericin. MEHTA, B. R. T., and LOPEZ-BERENSTEIN, G., Abstr. Gen. Meet, Am. Soc. Microbiol., 1991, 91, 22.
  • Liposomal-hamycin reduced toxicity and improved antifungal efficacy in vitro and in vivo. MEHTA, R. T., MCQUEEN, T. J., KAYHANI, A., and LOPEZ-BERESTEIN, G., Proc. Am. Assoc. Cancer Res. Annu. Meeting., 1991, 32, 431.
  • Temperature effects during interaction between cardiotonics and liposomes. MECNIK, I. Yu., Kriobiologiya, 1991, (2), 55.
  • Specific enzyme-induced decapsulation. MENGER, F. M., and JOHNSTON, D. E. JR., J. Am. Chem. Soc., 1991, 113, (14), 5467–5468.
  • In vitro evaluation of the association of thermosensitive liposome-encapsulated doxorubicin with hyperthermia. MERLIN, J. L., Eur. J. Cancer, 1991, 27, (8), 1031–1034.
  • Encapsulation of doxorubicin in thermosensitive small unilamellar vesicle liposomes. MERLIN, J. L., Eur. J. Cancer, 1991, 27, (8), 1026–1030.
  • Enhancement of the antibody response to a polysaccharide-based vaccine by synthesizing an artificial glycoprotein and using a novel microcapsule delivery system. MEUI.BROEK, J. A., Univ. Alabama, Birmingham, AL, USA, Dissertation, 1990, 166 pp.
  • Residual activity of microencapsulated permethrin against stable flies on lactating dairy cows. MEYER, J. A., and HUNTER, J. S. III, Med. Vet. Entomol., 1991, 5, (3), 359–362.
  • Equilibrium budding and vesiculation in the curvature model of fluid lipid vesicles. MIAO, L., FOURCADE, B., RAG, M., WORTIS, M., and ZIA, R. K. P., Phys. Rev. A, 1990, 43, (12), 6843–6856.
  • The effect of site administration in the gastrointestinal tract on the absorption of insulin from nanoparticles in diabetic rats. MICHEL, C., APRAHAMIAN, M., DEFONTAINE, L., COUVREUR, P., and DAMGE, C., J. Pharm. Pharntacol., 1991, 43, (1), 1–5.
  • Methods of reconstitution of the purified sarcoplasmic reticulum calcium-magnesium-ATPase using bile salt detergents to form membranes of defined lipid to protein ratios or sealed vesicles. MICHELANGELI, F., and MUNKONGE, F. M., Anal. Biochem., 1991, 194, (2), 231–236.
  • Liposomes enhance the oral availability of certain water-insoluble drugs. Micimus, M. J., Ann. N.Y. Acad. Sci., 1991, 618 (Temporal Control of Drug Delivery), 589–591.
  • Tertiary amines increase liposome permeability to hydrogen ions: an ESR study. MIHAILESCU, D., CONSTANTINESCU, A., TATAR, L., IONESCU, M. S., and FRANGOPOL, P. T., Rev. Rolm. Biochim., 1991, 28, (1-2), 49–56.
  • Phagocytosis of microspheres by granulocytes and cell recognition. MIYAMOTO, M., SASAKAWA, S., MIKAMI, Y., KAWAGUCHI, H., and 01ITSUKA, Y., Membrane, 1991, 16, (3), 151–162. Clinical application of chemotherapy via the portal vein with liposome-encapsulated adriamycin in inoperable metastatic liver cancer. MIZUNO, 1., IuunNo, T., YOTSUYANAGI, T., AKAMO, Y., YAMAMOTO, T., YASUI, T., ITABASHI, Y., SAITO, T., KURAHASHI, S., TANIMOTO, N., et al., Gan To Kagaku Ryoho, 1991, 18, (11), 1878–1883.
  • Large-scale use of hollow fiber and microencapsulated pink bollworm pheromone formul-ations integrated with conventional insecticides for the control of the cotton pest complex in Egypt. MOAWAD, G., KHIDR, A. A., ZAKI, M., CRITCHLEY, B. R., McVEicti, L. J., and CAMPION, D. G., Trop. Pest. Manage., 1991, 37, (1), 10–16.
  • Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. MOGIIIMI, S. M., PORTER, C. J. H., MUIR, I. S., ILLUM, L., and DAVIS, S. S., Biochem. Biophys. Res. Commun., 1991, 177, (2), 861–866.
  • Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunolipo-somes in vivo. Mom, A., KLIBANOV, A. L., TORCHILIN, V. P., and HuAxo, L., FEBS Lett., 1991, 284, (2), 263–266.
  • Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. MUELLER, S. C., and CHEN, W. T., J Cell Sc., 1991, 99, (2), 213–225.
  • The effect of block copolymers on the uptake of model polystyrene microspheres by Kupffer cells-in vitro and in vivo studies. MUIR, I. S., MOGHIMI, S. M., ILLIUM, L., DAVIES, S. S., and DAVIES, M. C., Biochem. Soc. Trans., 1991, 19, (3), 329S.
  • Biological availability of theophyffine from microcapsular formulations. MuRAB'Ev, I. A., MAKAROV, V. A., and ANDREEVA, I. N., Farmatsiya (Mose.), 1991, 40, (1), 36–38.
  • Adsorption of negatively charged microcapsules to a poly(2-hydroxyethyl methacrylate)/polyamine graft copolymer surface. MURAMATSU, N., YOSHIDA, Y., KATAYAMA, Y., OFISHIMA, H., and KONDO, T., J. Biomater. Sci., Polym. Ed., 1991,2, (2), 139–146.
  • Effect of inserted bacteriohopane-32-ol on the stability of liposomal membranes. NAGUMO, A., TAKANASHI, K., and SUZUKI, Y., Chem. Pharm. Bull., 1991, 39, (7), 1889–1891.
  • Preparation of microspheres by radiation-induced polymerization. I. Mechanism for the formation of monodisperse poly(diethylene glycol dimethacrylate) microspheres. NAKA, Y., KAETSU, I., YAMAMOTO, Y., and HAYAstit, K., J. Polym. Sci ., A: Polym. Chem., 1991,29, (8), 1197–1202.
  • Studies on preparation of microspheres by microencapsulation. NAKAHARA, Y., Kagaku Kogyo, 1991, 42, (7), 535–541.
  • Development of a new type of influenza subunit vaccine made by muramyl dipeptide-liposome: enhancement of humoral and cellular immune responses. NEROME, K., YOSHIOKA, Y., ISHIDA, M., OKUMA, K., OKA, T., KATAOAKA, T., INouu, A., and OYA, A., Vaccine, 1990, 8, (5), 503–509.
  • The effect of blood on the uptake of liposomal lipid by perfused rat liver. NICHOLAS, A. R., and Jorqus, M. N., Biochim. Biophys. Acta, 1991, 1074, (1), 105–111.
  • A phase I study of liposome-encapsulated gentamicin for treatment of MAI bacteremia in AIDS patients. NIGHTINGALE, S., SALETAN, S. R., CAI., S., LAWRENCE, J., WATSON, D., MANZONE, C., and BYRD, L., Istituto Superiore di Sanita. VII International Conference on AIDS: Science Challenging AIDS; Florence, Italy, 16–21 June, 1991. 464 pp. (Vol. 1); 460 pp. (Vol. 2). Istituto Superiore di Sanita, Rome, Italy, publ. 1991, p. 267B.
  • Optimization of the liposomes encapsulating a new lipopeptide CGP-31362 for efficient activation of tumoricidal properties in monocytes and macrophages. Nu, A., UTSUGI, T., FAN, D., DENKINS, Y., PAK, C., BROWN, D., VAN HOOGEVEST, P., and FIDLER, I. J., J. Immunother., 1991, 10, (4), 236–246.
  • Manufacturing technology and analysis of acetylsalicylic acid microcapsules. NIKOLAEV, A. S., and BARDAKOV, A, I., Farmatsiya (Mose.), 1991, 40, (2), 20–23.
  • Design and application study of cell microcapsulation instrument. N1NG, G. B., and Guo, M. Z., Chin. J. Biotechnol., 1989, 5, (2), 97–104.
  • Cholesterol sulfate-containing liposomes entrapping adriamycin: pharmacokinetics and antineoplastic effect. NODA, H., OGASAWARA, T., YAMAKAWA, H., IIDA, T., KURONO, M., and YAGI, K., J. Clin. Biochem. Nutr., 1991, 10, (3), 181–188.
  • Preparation and some properties of cholesterol sulfate-containing liposomes entrapping adriamycin. Norm, H., OGASAWARA, 'I'., YAMAKAWA, H., IIDA, T., KURONO, M., and YAGI, K., J. Clin. Biochem. Nutr., 1991, 10, (2), 83–92.
  • Sustained release injectable naltrexone microcapsules. NUWAYSER, E. S., DERoo, D. J., BA LSKOV I CH, P. D., and TsuR, A. G., N1DA Res. Monogr., 1991, 105, 532–583.
  • Thermosensitive microcapsules. II. New azomonomers, homo-, and cocondensation, micro-encapsulation, release measurements, size distribution and thermo-printing. NUYKEN, 0., DAUTH, J., and PEKRUHN, W., Angezv. Makromol. Chem., 1991, 190, 81–98.
  • Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclo-phosphamide, monoclonal antibodies, and magnetic microspheres. BRIANT, K. C., SHPALL, E. J., HOUSTON, L. L., PETERS, W. P., and BAST, R. C. JR., Cancer, 1991, 68, (6), 1272–1278.
  • Damage of egg phosphatidylcholine liposomes by DNA-binding cytotoxic agents. O'CONNOR, C. . j., DENNY, W. A., EMERY, D. P., TANK, H., SATO, T., and SUNAMOTO, J., Bull. Chem. Soc. Jpn., 1991, 64, (4), 1364–1369.
  • The use of microcapsules to study diet-induced intraluminal metabolic changes. P. Rozen, C. B. Reich and S. J. Winawer (Eds). Frontiers of Gastrointestinal Research, Vol. 18: Large Bowel Cancer: Policy, Prevention, Research and Treatment; 2nd International Conference on Gastroin-testinal Cancer, Jerusalem, Israel, 1989. 301. pp. S. Karger AG: Basel, Switzerland; publ. 1991, pp. 248–255.
  • Feasibility of targeted drug delivery to selective areas of the retina. OGURA, Y GURAN, T., SHAHIDI, M., Morn, M. T., and ZEIMER, R. C., Invest. Ophthalmol. 1/is. Sci., 1991, 32, (8), 2351–2356.
  • Effect of dextran sulfate on fusion of Sendai virus with human erythrocyte ghosts. Omo, S., ARNOLD, K., SRINIVASAKUMAR, N., and FLANAGAN, T. D., Thorned. Biochim. Acta, 1991, 50, (2), 199–206.
  • Formulation factors of pyrethroid microcapsules affecting rainfastness phytotoxicity and mammalian toxicity. OHTSUBO, T., TAKEDA, H., TSIJDA, S., and Tsuji, K., J. Pestle. Sci., 1991, 16, (3), 413–418.
  • Microencapsulated pesticide. OFITSUBO, T., TSUDA, S., and Tsuji, K., Shokubutsu Boeki, 1991, 45, (4), 165–168.
  • Antioxidant effect of vitamin K homologues on ascorbic acid/iron(H)-induced lipid peroxid-ation of lecithin liposomes. OHYASHIKI, T., YABUNAKA, Y., and MATSUI, K., Chem. Pharm. Bull., 1991, 39, (4), 976–979.
  • Redox-responsive liposomal system. Release of entrapped dye utilizing N,N'-diacylcystine as the functional amphiphile. OKABE, H., KAMAGAMI, S., KAINOSE, H., and ISHIGAMA, Y., Chem Express, 1991, 6, (5), 315–318.
  • Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of repeated administration of once-a-month injectable microspheres of leuprolide acetate. OKADA, II., HEYA, T., OGAWA, Y., TOGUCHI, H., and SHIMAMOTO, T., Pharm. Res., 1991, 8, (5), 584–587.
  • Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. OKADA, H., INouE, Y., HEYA, T., UENO, H., OGAWA, Y., and Tocuciti, H., Pharm. Res., 1991,8, (6), 787-791. Role of pentapeptide repeating sequence of elastin in coacervation and calcium ion transport. OKAMOTO, K., UEMURA, Y., KAIBARA, K., MIURA, M., KOZONO, Y., KAWATA, S., and KONDO, M., Pept. Chem., 1991, 28, 193–198.
  • Coating of certain matrix cores with aqueous-based systems of acrylate methacrylate, a water-insoluble copolymer and drug release profiles. OKOR, R. S., OTIMENYIN, S., and IjEH, I., J. Controlled Release, 1991, 16, (3), 349–354.
  • Liposomes. OKU, N., ACS Symp. Ser., 1991, 469 (Polym. Drugs Delivery Syst.), 24–33.
  • Production of submicron-size multi-hollow polymer microspheres by stepwise alkali/acid method. OKUBU, M., ICHIKAWA, K., and FujimugA, M., Polym. Mater. Sci. Eng., 1991, 64, 347–348.
  • Comparison of perturbation effect of propranolol, verapamil, chlorpromazine, and car-bisocaine on lecithin liposomes, and brain total lipid liposomes. An EPR spectroscopy study. ONDRIAS, K., STASKO, A., MISIK, V., REGLILI, J., and SVAJDLENKA, E., Chem. Biol. Interact., 1991, 79, (2), 197–206.
  • Interaction of lipid vesicles with monomolecular layers containing lung surfactant proteins SP-B or SP-C. OOSTERLAKEN-DIJKSTERHUIS, M. A., HAAGSMAN, H. P., VAN-GOLDE, L. M. G., and HEMEL, R. A., Biochemistry, 1991, 30, (33), 8276–8281.
  • Production of microcapsules by fluid bed. OSAKO, Y., and OKUDA, K., Kagaku Kogyo, 1991, 42, (7), 528–534.
  • Effects of protomin, rifampicin or clofazimine entrapped in liposomes on Mycobacterium leprae in cultured murine macrophages. OSAWA, N., and AKIYAMA, T., Kitasato Igaku, 1990, 20, (6), 547–553.
  • Effects of antimicrobial agents entrapped in liposomes on Salmonella enteritidis and Mycobacterium lepraernurium in cultured murine macrophages. OSAWA, N., and AKIYAMA, T., Kitasato Igaku, 1990, 20, (6), 538–546.
  • Annexin-mediated membrane fusion of human neutrophil plasma membranes and phos-pholipid vesicles. OSHRY, L., MEERS, P., MEAI.Y, T., and TAUBER, A. I., Biochim. Biophys. Acta, 1991, 1066, (2), 239–244.
  • Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomes. OUDARD, S., THIERRY, A., JORGENSEN, T. J., and RAHMAN, A., Cancer Chemother. Pharmacol., 1991, 28, (4), 259–265.
  • Preparation and characterization of polymer coated small unilamellar vesicles. OZDEN, M. Y., and HASIRCI, V. N., Biochim. Biophys. Acta, 1991, 1075, (1), 102–108.
  • %5-Fluorouracil nanocapsules. PAN, W. S., and Hu, J., Yaoxue Xuebao, 1991, 26, (4), 280-285. Localized rifampicin albumin microspheres. PANDE, S., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (1), 87–93.
  • Hydroxy-urea bearing albumin microspheres--preparation, characterization and evaluation. PANDE, S. K., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (1), 9–19.
  • Methyl ketone production in milk-fat-coated microcapsules. 2. Methyl ketones from con-trolled concentrations of free fatty acids. PANNELL, L. K., and OLSON, N. F. J. Dairy Sci., 1991, 74, (7), 2054–2059.
  • Methyl ketone production in milk-fat-coated microcapsules. 1. Variation of lipase and spore concentrations. PANNELL, L. K., and OLSON, N. F., J, Dairy Sci., 1991, 74, (7), 2048-2053. Liposomes. Controlled release of active ingredients. PANTINI, G., and BENCINI, P. L., Tecnol.
  • Chim., 1991, 11, (4), 112–117.
  • Polymorphonuclear leukocyte degranulation with exposure to poly(methyl methacrylate) nanoparticles. PAPATHEOFANIS, F. J., and BARMADA, R., J. Biomed. Mater. Res., 1991, 25, (6), 761–771.
  • Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. PAPPO, J., ERMAK, T. H., and STEGER, H. J., Immunology, 1991, 73, (3), 277–280.
  • Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. PARASASSI, T., DE STASIO, G., RAVAGNAN, G., RUSCH, R. M., and GRATTON, E., Biophys. J 1991, 60, (1), 179–189.
  • Analysis of drug release from gelatin-glutaraldehyde microspheres accompanying degrad-ation by protease. PARK-CHAN-YOUNG, KANG-YONG-GU, KIM-JAR-GAP, and CHO-CHONG-HYUN, Hwahak Konghak, 1990, 28, (6), 699–705.
  • Tissue specific serum opsonins and phagocytosis of liposomes. PATEL, H. M., and MOGHIMI, S. M., NATO ASI Ser, Ser. A, 1990, 199 (Targeting Drugs 2), 87–94.
  • Lipophilic cisplatin analogs entrapped in liposomes role of chemical structure and liposome composition. PEREZ SOLER, R., SIDDIK, Z. H., AL BAKER, S., FRANCIS, K., YANG, L. Y., and KHOKHAR, A. R., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 408.
  • Preclinical studies with a lipophilic anthracycline derivative entrapped in liposomes. PEREZ SOLER, R., BROWN, T., and PRIEBE, W., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 381.
  • Preparation and use of liposomes with incorporated chloroplast envelope proteins to study ion transport. PETERS, J., LONGHI, D., and BERKOWITZ, G., Plant Physiol., 1991, 96, (1, Suppl.), 37.
  • Effects of age-dependent or liposome-induced alterations in the phospholipid composition on sphingomyelin biosynthesis in rat liver microsomal and plasma membranes. PETKOVA, D. H., NIKOLOVA, M. N., KOCHLUKOVA, S. E., and KOUMANOV, K. S., Int. J. Biochem., 1991, 23, (7-8), 689–693.
  • Ischemia/reperfusion-induced changes in membrane fluidity characteristics of brain capillary endothelial cells and its prevention by liposomal-incorporated superoxide dismutase. PHELAN, A. M., and LANGE, D. G., Biochim. Biophys. Acta, 1991, 1067, (1), 97–102.
  • Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosup-pression. PHILLIPS, N. C., SKAMENE, E., and TSOUKAS, C., J. Acquir. Immune Defic. Syndr., 1991, 4, (10), 959–966.
  • Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice. PHILLIPS, N. C., and TSAO, M. S., Cancer Imrnunol. Immunother., 1991, 33, (2), 85–90.
  • Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: effects on antimicrobial resistance. PINTO, A. J., STEWART, D., VAN ROOIJEN, N., and MORAHAN-PAGE, S., J. Leukocyte Biol., 1991, 49, (6), 579–586.
  • Microcapsules of sodium 2,3-ciimercaptopropane sulfonate (unithiol). PORTNYAGINA, V. A., FEDOROVA, I. P., POCHINOK, T. V., TARAKHOVSKII, M. L., ZADOROZHNAYA, T. D., and YATSENKO, K. V., Farmatsiya (Mosc.), 1991, 40, (2), 24–27.
  • Phospholipid vesicles containing bovine heart mitochondrial cytochrome c oxidase exhibit proton translocating activity in the presence of gramicidin. PROCHASKA, L. J., and WILSON, K. S., Arch. Biochem. Biophys., 1991, 290, (1), 179–185.
  • Therapeutic aspects of liposomes. PUISIEUX, F., BARRATT, G., ROBLOT-TREUPEL, L., DELATTRE, J., COUVREUR, P., and DEVISSAGUET, J. P., Phospholipids: Biochem. Pharm. Anal. Consid., (Proc. Int. Colloq. Lecithin), 5th, 1989, Plenum, New York, N.Y., USA; publ. 1990, pp. 133–165. Eds: I. Hanin and G. Pepeu.
  • Study of abietic acid glycerol derivatives as microencapsulating materials. PURANIK, P. K., and DORLE, A. K., J. Microencapsulation, 1991, 8, (2), 247–252.
  • Reduction of the in vitro hemolytic activity of soybean lecithin liposomes by treatment with a block copolymer. QUIRION, F., and ST. PIERRE, S., Biophys. Chem., 1991, 40, (2), 129–134.
  • Controlled-release tablets of ethyl cellulose coated salbutamol sulphate microcapsules. RAGHUBANSHI, R. S., JAYASWAL, S. B., and SINGH, J., Pharmazie, 1991, 46, (2), 144–145.
  • Liposomal amphotericin B, an effective nontoxic preparation for the treatment of urinary tract infections caused by Candida Albicans. RAI-PH, E. D., BARBER, K. R., and GRANT, C. W. M., Am. J. Nephrol., 1991, 11, (2), 118–122.
  • Hydrolysed microspheres from cross-linked polymethyl methacrylate (Hydrogel). A new embolic material for interventional neuroradiology. RAO, V. R., RAVIMANDALAM, K., JAYAKRISHNAN, A., THANOO, B. C., RADHAKRISIINAN, V. V., GUPTA, A. K., KUMAR, S., JOSEPH, S., UNNI, M., and RAO, A. S., J. Neuroradiol., 1991, 18, (1), 61–69.
  • Efficient entrapment of amikacin and teicoplanin in liposomes. RAVAOARINORO, M., TOMA, E., AGBABA, 0., and MORISSET, R., Abstr. Gen. Meet. Am. Soc. Microbiol., 1991, 91, 22.
  • pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. REDDY, R., ZHOU, F., HUANG, L., CARBONE, F., BEVAN, M., and ROUSE, B. T., J. Immunol. Methods, 1991, 141, (2), 157–163.
  • The experimental evidence at isolated membrane and reconstituted liposome level for membrane transport mechanisms in plant cells. REINHOLD, L., BRAUN, Y., HASSIDIM, M., COOPER, S., and LERNER, H. R., Physiol. Plant, 1991, 82, (3), B19.
  • Test method for evaluating the permeability of intact prophylactics to viral-size microspheres under simulated physiologic conditions. RETTA, S. M., HERMAN, W. A., RINALDI, J. E., CAREY, R. F., HERMAN, B. A., and ATHEY, T. W., Sex. Transm. Dis., 1991, 18, (2), 111–118.
  • Liposomes as models to study the distribution of porphyrins in cell membranes. RICCHELLI, F., JOB, G., GOBBO, S., and TRONCHIN, M., Biochim. Biophys. Acta, 1991, 1065, (1), 42–48.
  • Anti-CD4 MAB labelled liposomes as selective vehicles for AZT. BOMBI, G., Pm, G., PIRO, S., PAUTASSO, M., GARAO, G., and PALOMBA, A., Istituto Superiore di Sanita. VII International Conference on AIDS: Science Challenging AIDS; Florence, Italy, 16–21 June, 1991. 464 pp. (Vol. 1); 460 pp. (Vol. 2). Istituto Superiore di Sanita: Rome, Italy, publ. 1991, p. 112B.
  • Cross-linked degradable starch microspheres as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis, degradation and relaxation properties. RONGVED, P., LINDBERG, B., and KLAVENESS, J., Carbohydr. Res., 1991, 214, (2), 325–330.
  • Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres. Roos, G., El. HAG IMAD, A., TEDER, H., and STENRAM, U., Anticancer Res., 1991, 11, (1), 13–16.
  • A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(n,L-lactide-co-glycolide). Rosimo, V., BENOIT, J. P., DEYME, M., THIES, C., and MADELMONT, G., J. Biomed. Mater. Res., 1991, 25, (5), 667–682.
  • Multivesicular liposomes containing bleomycin for subcutaneous administration. Roy, R., and KIM, S., Cancer Chemother. Pharmacol., 1991, 28, (2), 105–108.
  • In vivo peptide release from poly(DL-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. Ruiz, J. M., and BENOIT, J. P., J. Controlled Release, 1991, 16, (1-2), 177–185.
  • Studies on the release of theophylline from poly(vinyl acetate) microspheres. SA, B., Drug. Dev. Ind. Pharm., 1991, 17, (6), 893–900.
  • Effect of 2.45 GHz microwave radiation on permeability of unilamellar liposomes to 5(6)-carboxyfluorescein. Evidence of non-thermal leakage. SAALMAN, E., NORDEN, B., ARVIDSSON. L., HAMNERIUS, Y., HOJEVIK, P., CONNELL, K. E., and KURUCSEV, T., Blochim. Biophys. Acta, 1991, 1064, (1), 124–130.
  • A study of the stability of hemoglobin-containing liposomes. SABLINA, M. A., USHAKOVA, I. P., SEREBRENNIKOVA, G. A., and EVSTIGNEEVA, R. P., Biol. Membr., 1991, 8, (3), 292–296.
  • Study of stroma promoting factor on carcinoma cell using alginic acid microcapsule: preliminary report. SAKAI, Y., Mom, H., CHIN, M., TAKAHASHI, N., TENJIN, T., KITA, T., and SHOJI, T., Nippon Geka Gakkai Zasshi, 1991, 92, (5), 615.
  • Effects of liposome-incorporated valinomycin in combination with cisplatin and other platinum analogues in human ovarian carcinoma cells. SAKATA, M. K., and DAOUD, S. S., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 344.
  • Interaction of the 140/130/110 kDa rhoptry protein complex of Plasmodium falciparum with the erythrocyte membrane and liposomes. SAM YELLOWE, T. Y., and PERKINS, M. E., Exp. Parasitol., 1991, 73, (2), 161–171.
  • Liposomal delivery of purified heat shock protein HSP70 into rat pancreatic islets protects against interleukin-1-B induced impaired beta-cell function. SANDLER, S., MARGULIS, B. A., EIZIRIK, D. L., WELSH, N., and WELSH, M., Acta endocrinol., Suppl, 1991, 124, (3), 32. Phase diagram studies for microencapsulation of pharmaceuticals using cellulose acetate trimellitate. SANtaivi, S. P., and NAIRN, J. G., J. Pharm. Sci., 1991, 80, (4), 394–398. Highly stable liposomes derived from perfluoroalkylated glycerophosphocholines. SANTAELLA, C., VIERLING, P., and RIESS, J. G., Angew Chem. Int. Ed. Engl., 1991, 30, (5), 567–568. Partitioning and membrane disordering effects on ethanol and other n-alkanols in phosphatidylcholines and biologically relevant lipid mixtures. SARASUA, M., TOLENTINO, M., SMITH, R., CHANG, H., and ATIENZA, A., Ann. NY. Acad. Sci., 1991, 625, 760–763.
  • Production of antibodies to dextran using liposome as adjuvant. SARKAR, A. K., and DAS, M. K., Immunol. Invest., 1991, 20, (3), 243–253.
  • Liposomes as a selective ocular drug delivery system. SARKAR, R. P., Northeast Louisiana Univ., Monne, LA, USA, Dissertation, 1990, 131 pp.
  • Immunotherapeutic effects of autologous liposome-borne tumor-specific transplantation antigens in combination with cyclophosphamide on postsurgical tumor recurrence in mice. SATO, T., SATO, N., KIKUCHI, K., HIRATA, K., and LEGRUE, S. J., Tumor Res., 1990, 25, 21–36.
  • Double fluorescent labeling method used for a study on liposomes. SAWAHARA, H., GOTO, S., and KINOSHITA, N., Chem. Pharm. Bull., 1991, 39, (1), 227–229.
  • Infective endocarditis: the effect of liposomes as carrier substance for alpha-1 antitrypsin and ampicillin. SCHAAF, H. S., BATES, W. D., IIANEKOM, C., NEITELER, B. F., KRIEGLER, A. B., and VAN DER MERWE, P. L., SAMJ (S. Afr. Med. J.), 1991, 79, (10), 588–590.
  • Transient inhibition of liver regeneration in mice by transforming growth factor-beta 1 encapsulated in liposomes. SCFIACKERT, H. K., FAN, D., and FIDLER, 1. J., Cancer Commun., 1990,2, (5), 165–171.
  • Sensitization in vitro of human peripheral blood mononuclear cells to phenolic glycolipid 1 of Mycobacterium leprae in liposomes. SCHAUE, V., HOLOBAUGH, P., MILLER, P., and MITTAI., K., Cell Immunol., 1991, 137, (1), 81–87.
  • Liposomes for oral application. 2. Preparation and characterization of streptokinase liposomes for oral application. SCHMIDT, P. C., and MICHAELIS, J., PZ Wiss., 1990, 3, (6), 233–242.
  • Liposome-mediated delivery of melanin to non-pigmented cells as basis for the study of the biological role of melanin pigmentation. SCHMITZ, S., ALLEN, T. m., Juunow, K., and HANSEN, C., Clin. Res., 1991, 39, (2), 541A.
  • Loading of preformed liposomes with high trapping efficiency by detergent-induced form-ation of transient membrane holes. SCHUBERT, R., WOLI3URG, H., SCHMIDT, K. H., and ROTH, H. J., Chem. Phys. Lipids, 1991, 58, (1-2), 121–129.
  • Safety and efficacy of liposomal amphotericin B in treating AIDS-associated disseminated cryptococcosis (letter). SCHURMANN, D., DE MATOS MARQUES, B., GRUNEWALD, T., POHLE, H. D., HAHN, H., and RUE, B., J. Infect. Dis., 1991, 164, (3), 620–622.
  • Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes, and analysis of their pharmacokinetic properties, acute toxicity,, and antitumor efficacy. SCHWENDENER, R. A., FIEBIG, H. H., BERGER, M. R., and BERGER, D. P., Cancer Chemother. Pharmacol., 1991, 27, (6), 429–439.
  • Intravenous administration of amphotericin B entrapped in liposomes: induction of high serum levels of TNF alpha. Ann. Oncol., 1991, 2, (2), 141–144.
  • Reversal of murine tumor cell resistance to vinblastine by presentation of the drug in multilamellar liposomes. SETD, C., FAN, D., CI.YNE, R. K., EARNEST, L. E., and FIDLER, I. J., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 372.
  • Adhesion of vesicles in two dimensions. SEIFERT, U., Phys. Rev. A, 1991, 43, (12), 6803-6814. The morphogenesis of liposomes viewed from the aspect of bending energy. SEKIMURA, T., and HOTANI, H., J. Theur. Biol., 1991, 149, (3), 325–337.
  • IL2 liposomes as a tumor vaccine adjuvant improved local and systemic protection. SENCER, S., RICH, M., and ANDERSON, P., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 255.
  • Beneficial effect of liposomal encapsulated superoxide dismutase on ischemically injured liver in the rat. SENGA, S., ONITUKA, A., HIROSE, H., YAMAMOTO, K., and NIWA, K., Artif. Organs, 1990, 14, (Suppl. 3), 228–229.
  • Effect of different binders on release characteristics of theophylline from compressed microspheres. SHAIKH, N. H., DE VANES, S. E., SHIJKLA, A. J., BLOCK, L. H., COLLINS, C. C., and PRICE, J. C., Drug Dev. Ind. Pharm., 1991, 17, (6), 793–804.
  • A preliminary study on liposome encapsulated human interferon-alpha by resisting trypsin digestion in vitro. SHAN, F., and LIANG, Z., J. China Med. Univ., 1990, 19, (Suppl.), 6–9. 24.
  • Microcapsules through polymer complexation. II. By complex coacervation of polymers containing a low charge density. SHAO, W., YIN, X., STEVENSON, W. T., and ALEXANDER, H., Biomaterials, 1991, 12, (5), 479–488.
  • Microcapsules through polymer complexation. I: Complex coacervation of polymers contain-ing a high charge density. SHAO, W., YIN, X., and STEVENSON, W. T. K., Biomaterials, 1991, 12 (4), 374–384.
  • Effect of solid dispersing agents on the formation of rosin microcapsules. SHEOREY, D. S., and DORLE, A. K., J. Microencapsulation, 1991, 8, (1), 79–82.
  • Effect of solvents on the characteristics of rosin walled microcapsules prepared by a solvent evaporation technique. SHEOREY, D. S., and DORLE, A. K., J. Microencapsulation, 1991,8, (1), 71–78.
  • Release kinetics of drugs from rosin glycerol ester microcapsules prepared by solvent evaporation technique. SHEOREY, D. S., and DoRLE, A. K., J. Microencapsulation, 1991,8, (2), 243–246.
  • Study of some improved shellac derivatives as microencapsulating materials. SHEOREY, D. S., KSHIRSAGAR, M. D., and DORLE, A. K., J. Microencapsulation, 1991, 8, (3), 375–380.
  • A new technique for the encapsulation of water-insoluble drugs using ethyl cellulose. SHEOREY, D. S., SAL, M. S., and DORLE, A. K., J. Microencapsulation, 1991, 8, (3), 359–368.
  • Liposomes as carriers of cisplatin in the central nervous system experiments with 9L gliomas in rats. SHIBATA, S., OCHI, A., and MORI, K., Neural. Med. Chir., 1990, 30, (4), 242–245.
  • Microencapsulation of human cells its effects on growth of normal and tumor cells in vitro. SHIMI, S. M., HOPWOOD, D., NEWMAN, E. L., and Cuscrx IERI, A., Br. J. Cancer, 1991, 63,(5), 675–680.
  • Semi-permeable microcapsules for cell culture ultrastructural characterization. SHIM, S. M., NEWMAN, E. L., HOPWOOD, D., and CUSHIER, A., J. Microencapsulation, 1991, 8, (3), 307–316. Protective effects of liposomal superoxide dismutase in rat brain. SHIN, D. J., BAEK, K. J., and
  • LEE, H. S., Chung Ang J. Med., 1990, 15, (4), 329–336.
  • Encapsulation with chitosan. SHIOYA, T., Sen'i Gakkaishi, 1990, 46, (12), P576–P580.
  • The physicochemical effect of coacervation conditions on the diffusional properties and surface morphology of biodegradable microcapsules. SHIVELY, M. L., and McNicKLE, T. M., Drug Dee. Ind. Pharm., 1991, 17, (6), 843–864.
  • Modulation of multidrug resistance in HL-60 leukemia cells by adriamycin encapsulated in liposomes. SIDDIQUI, J., MADHU, M., CENTER, M., GLAZER, R., DRITSCHILO, A., and RAHMAN, A., Assoc. Cancer Res. Annu. Meet., 1991, 32, 375.
  • Controlled delivery of diphtheria toxoid using biodegradable poly(DL-lactide) microcapsules. SINGH, M., SINGH, A., and TALWAR, G. P., Pharm. Res., 1991, 8, (7), 958–961.
  • Direct determination of protein concentration for proteins immobilized on microspheres. SLOMKOWSKI, S., and BASINSKA, T., Polym. Mater. Sci. Eng., 1991, 64, 318–319.
  • Liposomal amphotericin B and erythrocyte echinocytosis. SMITH, 0. P., and PRENTICE, H. G., Bone Marrow Transplant., 1991, 8, (2), 155–156.
  • The in situ immune response of the rat after intraperitoneal depletion of macrophages by liposome encapsulated dichloromethylene diphosphonate. SOESATYO, M., BIEWENGA, J., VAN ROOIJEN, N., and SMINIA, T., Gastroenterology, 1991, 100, (5, Part 2), A617.
  • New trends in microencapsulation of physiologically-active substances-homogenization of liquid diphase systems. Theory and applications. SOLODOVNIK, V. D., Med. Prog. Technol., 1991, 17, (1), 49–54.
  • Analysis of correlation between the permeability of phosphatidylcholine liposomes for glucose on the prostaglandin content. SOROKINA, A. D., YANOPOL'SKAYA, N. D., SIVAS, I. M., YAILENKO, T. L., and BOGUSLAVSKIL L. I., Biokhimiya, 1991, 56, (4), 747–752.
  • Nanoparticles and liposomes: a state of the art. SPEISER, P. P., Methods Find. Exp. Clin. Pharmacol., 1991, 13, (5), 337–342.
  • Microcarriers for animal cell biotechnology: an unfulfilled potential. SPIER, R. E., and MAROUDAS, N., Biotechnology, 1991, 17, 191–212.
  • Interaction of non-enveloped plant viruses and their viral coat proteins with phospholipid vesicles. Sratorr, R. B., BOHMER, M. R., WILSCHUT, J., and HEMMINGA, M. A., Biochim. Biophys. Ada, 1991, 1065, (2), 217–224.
  • High antibody titers in mice with polymethylmethacrylate nanoparticles as adjuvant for HIV vaccines. STEINEKER, F., KREUTER, J., and LOEWER, J., AIDS, 1991, 5, (4), 431–436.
  • Liposomes as carriers for cosmetics-a freeze-fracture electron microscopy study. STERNBERG, B., and SCHNEIDER, M., Phospholipids: Biochem. Pharm. Anal. Consid. (Proc. Mt. Colloq. Lecithin),5th, 1989, Plenum, New York, N.Y., USA; publ. 1990, pp. 291–294. Eds: 1. Hanin and G. Pepeu.
  • Biodegradable microspheres. XIII: Immune response to the DNP hapten conjugated to polyacryl starch microparticles. STJARNKVIST, P., DEGLING, L., and SJOHOLM, I., J. Pharm. Sci., 1991, 80, (5), 436–440.
  • Microencapsulation of bacteria for in situ aquifer bioremediation. STORMO, K. E., and CRAWFORD, R. L., Abstr. Gen. Meet. Am. Soc. Microbial., 1991, 91, 288.
  • Bioavailability of griseofulvin in the form of liposomes. STOZEK, T., and BORYSIEWICZ, J., Pharmazie, 1991, 46, (1), 39–41.
  • Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. STRAUSS, L. C., TRISCHMANN, T. M., ROWLEY, S. D., WILEY, J. M., and CIVIN, C. 1., Am. J. Pediatr. Hematol. Oncol., 1991, 13, (2), 217–221.
  • Phospholipid liposomes as drug carriers: preparation and properties. STRICKER, H., Phospholipids: Biochem. Pharm. Anal. Consid. (Proc. Int. Colloq. Lecithin), 5th, 1989, Plenum, New York, USA; publ. 1990, pp. 115–122. Eds: I. Hanin and G. Pepeu.
  • Liposomes as cyclosporin A carriers: the influence of ordering of hydrocarbon chains of phosphatidylglycerol liposomes on the association with and topography of cyclosporin A. STUHNE-SEKALEC, L., and STANACEV, N. V., J. Microencapsulation, 1991, 8, (3), 283–294.
  • Liposomes as carriers of macrolides: preferential association of erythromycin A and azithromycin with liposomes of phosphatidylglycerol containing unsaturated fatty acid(s). STUHNE-SEKALEC, L., STANACEV, N. Z., and DJOKIC, S., J. Microencapsulation, 1991, 8, (2), 171–184.
  • A possible function of phosphonolipid. Effect of ceramide 2-aminoethylphosphonate on liposomal glycolipid antigen-antibody reaction. SUGITA, M., ITONORI, S., Fujii, H., ITASAKA, 0., and Horn, T., Shiga Daigaku Kyoikugakubu Kiyo, Shizen Kagaku, Kyoiku Kagaku, 1990, (40), 35–39.
  • Newly developed fusogenic liposome. SUNAMOTO, J., AKIYOSHI, K., TANAKA, K., and SATO, T., Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.), 1990, 31, (2), 155–156.
  • Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody. SUZUKI, H., Nippon Geka Gakkai Zasshi, 1991, 92, (3), 257–265.
  • Studies on liposomal ferromagnetic particles and a technique of high frequency inductive heating. In vivo studies of rabbits. SUZUKI, S., ARAI, K., KOIKE, T., and OGUCHI, K., J. Jpn. Soc. Cancer Ther., 1990, 25, (11), 2649–2658.
  • Prospects for the therapeutic use of liposome in the medical practice. SYNOVETS, 0. A., LAPSHIN, D. E., and RUDENKO, IU, V., Vrach. Delo., 1991, (6), 16–20.
  • Detection of cell surface components using fluorescent microspheres. SYTKOWSKI, A. J., Methods Enzymol., 1990, 184 (Avidin-Biotin. Technol.), 353–356.
  • The cryopreservation of liposomes 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing-thawing. TALSMA, H., VAN STEENBERGEN, M. J., SALEMINK, P. J. M., and CROMMEI,IN, D. J. A., Pharm. Res., 1991, 8, (8), 1021–1026.
  • A novel positively-charged lipid 1,2-bishexadecylcyclooxy-3-trimethylaminopropane (BIS-HOP) enhances the adjuvant effect of liposomes on encapsulated tetanus toxoid. TAN, L., and GREGORIADIS, G., Asian Pac. J. Allergy Immunol., 1991, 9, (1), 21–24.
  • Comparison of the immune response against polio peptides covalently-surface-linked to and internally-entrapped in liposomes. TAN, L., WEISSIG, V., and GREGORIADIS, G., Asian Par. 3. Allergy Immunol., 1991, 9, (1), 25–30.
  • Preparation of microcapsules having adhered layer of ferrite powder on interface between wall material and core material. TANAKA, M., INABA, K., and KIMURA, I., Shikizai Kyokaishi, 1991, 64, (2), 64–73.
  • Membrane disorders of Escherichia coli cells and liposomes induced by hydroxybenzoic acid esters: the antimicrobial action of p-hydroxybenzoic acid esters. V. TATSUGUCHI, K., KUWAMOTO, S., OGOMORI, M., IDE, T., and WATANABE, T., J. Food Ilyg. Soc. Jpn., 1991, 32, (3), 121–127.
  • Tantalum loaded silicone microspheres as particulate emboli. THAN00, B. C., and JAYAKRISHNAN, A., J. Microencapsulation, 1991, 8, (1), 95–101.
  • Tantalum-loaded polyurethane microspheres for particulate embolization: preparation and properties. THANOO, B. C., SUNNY, M. C., and JAYAKRISHNAN, A., Biomaterials, 1991, 12, (5), 525–528.
  • Liposome adjuvanticity: influence of dose and protein: lipid ratio on the humoral response to encapsulated and surface-linked antigen. THERIEN, H. M., SHAHUM, E., and FORTIN, A., Cell. Immunol., 1991, 136, (2), 402–413.
  • Modulation of multidrug resistance by antisense oligodeoxynucleotide encapsulated in liposomes. THIERRY, A. R., RAHMAN, A., VIGE, D., NOTARIO, V., and DRITSCHILO, A., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 433.
  • Modulation of multidrug resistance by liposomally encapsulated doxorubicin in two human MDR tumor cell lines. THIERRY, A. R., VICE, D., DRITSCHILO, A., and RAHMAN, A., Proc. Am. Cancer Res. Annu. Meet., 1991, 32, 373.
  • Multidrug resistance in Chinese hamster cells: effect of liposome-encapsulated doxorubicin.
  • THIERRY, A. R., JORGENSEN, T. J., FORST, D., BELLI, J. A., DRITSCHILO, A., and RAHMAN, A., Cancer Commun., 1989, 1, (5), 311–316.
  • Functional incorporation of the ATP-activated tonoplast amino acid carrier into phosphatidyl-choline liposomes. THUME, M., and DIETZ, K. J., Plant Physiol., 1991, 96, (1, Suppl.), 159.
  • An improved method for the preparation of liposomal gadolinium-DTPA. Ionophore-mediated active entrapment of gadolinium. TILCOCK, C. P., AHKONG, Q. F., and PARR, M., Invest. Radiol., 1991, 26, (3), 242–247.
  • Therapeutic efficacy of liposome-encapsulated kinamycin against Mycobacterium intra-cellulare infection induced in mice. TOMIOKA, H., SAITO, H., SATO, K., and YONEYAMA, T., Am. Rev. Respir. Dis., 1991, 144, (3, Pt 1), 575–579.
  • Indium-111 -labeled phospholipid vesicles liposomes imaging in detection of primary lung cancer: preliminary results. TONTHAT, T., TAILLEFER, R., DURANCEMI, A., LAFONTAINE, E., DESCHAMPS, C., LAMBERT, R., LABONTE, C., and NORMAN, L., J. Nucl. Med., 1991,32, (5, Suppl.), 1085.
  • Indium-111 labeled antibody targeted long-lived liposomes. TORCHILIN, V. P., KLIBANOV, A, O'DONNELL, S., NOSSIFF, N., STRAUSS, H. W., and KHAW, B. A., J. Nucl. Med., 1991, 32, (5, Suppl.), 992.
  • Microaggregated egg albumin particles containing paracetamol for tableting processes. TORRADO, D. J. J., TORRADO, V. J. J., and CADORNIGA, R., Drug Dev. Ind. Pharm., 1991, 17, (10), 1305–1323.
  • Targeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disposition. Tsuji, H., OSAKA, S., and KIWADA, H., Chem. Pharm. Bull., 1991,39, (4), 1004–1008.
  • Preparation of enteric-coated Mycoplasma hyopneumoniae vaccine microcapsules by drying in oil process. TZAN, Y. L., LEE, C. J., UN, S. Y., and WENG, C. N., J. Chin. Soc. Vet. Sci., 1990, 16, (2), 95–102.
  • Preparation of pullulan acetate phthalate microcapsules containing drug and its dissolution test. UCHIDA, T., NAKAMURA, H., YASUTAKE, T., FUJIMOTO, I., GOTO, S., and AOYAMA, T., Yakuzaigaku, 1990, 50, (4), 360–368.
  • In vivo evaluation of pullulan acetate phthalate microcapsules containing drug in beagle dogs. UCHIDA, T., NAKAMURA, H., YASUTAKE, T., and GOTO, S., Yakuzaigaku, 1990, 50, (4), 369–375.
  • Basic study on hepatic artery chemoembolization using temperature-sensitive liposome in the treatment of hepatic tumor: animal experiment. UENO, M., ZOU, Y. Y., Oxo, A., and HORIKOSHI, I., Gan To Kagaku Ryoho, 1991, 18, (12), 2183–2185.
  • Characteristics of the membrane permeability of temperature-sensitive liposome. UENO, M., YOSHIDA, S., and HORIKOSHI, I., Bull. Chem. Soc. Jpn., 1991, 64, (5), 1588–1593.
  • Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetics. URANO, S., HOSHI-HASHIZUME, M., TOCHIGI, N., MATSUO, M., SHIRAKI, M., and ITo, H., Lipids, 1991, 26, (1), 58–61.
  • Membrane stabilizing effect of vitamin E: existence of a hydrogen bond between alpha-tocopherol and phospholipids in bilayer liposomes. URANO, S. KITAHARA, M., KATO, Y HASEGAWA, Y., and MATSUO, M., J. Nutr. Sci. Vitaminol., 1990, 36, (6), 513–519.
  • Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages. UTSUGI, T., NH, A., FAN, D., PAR, C. C., DENKINS, Y., VAN HOOGEVEST, P., and FIDLER, I. J., Cancer Immunol. Immunother.,1991, 33, (5), 285–292.
  • In situ activation of mouse macrophages and inhibition of spontaneous metastasis of renal cell carcinoma by liposomes containing CGP-31362. UTSUGI, T., DINNEY, C. P. N., KILLION, J. J., and FIDLER, I. J., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 233.
  • Preparation and characterization of liposomal-lipophilic tumor necrosis factor. UTSUMI, T., HUNG, M. C., and KLOSTERGAARD, J. Cancer Res., 1991, 51, (13), 3362–3366.
  • Proton-motive force-driven D-galactose transport in plasma membrane vesicles from the yeast Kluyveromyces marxianus. VAN LEEUWEN, C. C., POSTMA, E., VAN DEN BROEK, P. J., and VAN STEVENINCK, J., J. Biol. Chem., 1991, 266, (19), 12146–12151.
  • A fluorescence method for the determination of the molecular weight cut-off of alginate-polylysine microcapsules. VANDENBOSSCHE, G. M., VAN OOSTVELDT, P., and REMON, J. P., J. Pharm. Pharmacol., 1991, 43, (4), 275–277.
  • Quantitative analysis at the molecular level of laser-neural tissue interactions using a liposome model system. VANDERMEULEN, D. L., MISRA, P., MICHAEL, J., SPEARS, K. G., and KHOKA, M., Proc. SPIE Int. Soc. Opt. Eng., 1991, 1428 (Proc. Three-Dimens. Bioimaging Syst. Lasers Neurosci., 1991), 91–98.
  • Complex coacervates involving protein biopolymer pairs. VEIS, A., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1991, 32, (1), 596–597.
  • Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen. VERMA, J. N., WASSEF, N. M., WIRTZ, R. A., ATKINSON, C. T., AIKAWA, M., Loomis, L. D., and ALVING, C. R., Biochim. Biophys. Acta, 1991, 1066, (2), 229–238.
  • Double-labeling technique in the evaluation of nasal mucoadhesion of disodium cromogly-cate microspheres. VIDGREN, P., VIDGREN, M., VAINIO, P., NUUTINEN, J., and PARONEN, P., Int. J. Pharm., 1991, 73, (2), 131–136.
  • Encapsulation of europium in liposomes for use in an amplified immunoassay detection system. VONK, G. P., and WAGNER, D. B., Clin. Chem., 1991, 37, (9), 1519–1520.
  • Phase I trial of Immther, a new liposome-incorporated lipophilic disaccharide tripeptide. VOSIKA, G. J., CORNELIUS, D. A., GILBERT, C. W., SADLIK, J. R., BENNEK, J. A., DOYLE, A., and HERTSGAARD, D., J. Immunother., 1991, 10, (4), 256–266.
  • The use of liposomes for the preparation of protein-free lipid emulsions models of chylomicron remnants. VUARIDEL-BONANOM I, E. S., and WEDER, H. G., J. Microencapsulation, 1991, 8, (2), 203–214.
  • Development and characterization of pseudolatex based transdermal drug delivery system of diclofenac. VYAS, S. P., Gouot, P. J., and JAIN, S. K., Drug Den. Ind. Pharm., 1991, 17, (8), 1041–1058.
  • Single channel proton currents in CFOCF1 proteoliposomes. WAGNER, R., APLEY, E. C., and HANKE, W., Curr. Res. Photosynth. Proc. Int. Conf. Photosynth. 8th, 1989, Kluwer, Dordrecht, Neth., publ. 1990, pp. 93–96. Ed: M. Baltscheffsky.
  • Magnetic resonance imaging study of the rat cerebral ventricular system utilizing intra-cerebrally administered contrast agents. WAN, X., Fu, T. C., SMITH, P. H., BRAINARD, J. R., and LONDON, R. E., Magn. Reson. Med., 1991, 21, (1), 97–106.
  • Hepatic arterial infusion of cisplatin microspheres for transplantable hepatocellular carcinoma in rats. WANG, Y., Chung Hua Chung Liu Tsa Chih, 1991, 13, (1), 40–42.
  • Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of 'stealth' lipids. WASSEF, N. M., MATYAS, G. R., and ALVING, C. R., Biochem. Biophys. Res. Commun., 1991, 176, (2), 866–874.
  • In vivo evaluation of oxygen carrying capacity of completely artificial liposome heme. WATANABE, M., KOBAYASHI, K., ISHIHARA, T., FUKUZUMI, M., NISH1DE, H., and TSUCHIDA, E., Artil Organs, 1990, 14, (Supp. 3), 213–214.
  • Circular dichroism studies of conformation and interaction of the cyclohexenone and acetyl group of progesterone with liposomes. WATANABE, S., SAITO, T., SANCHEZ-BUENO, A., and SANCHO, M. J., Jpn. J. Pharmacol., 1991, 55, (Suppl. 1), 120p.
  • Extraction of copper(II) into microcapsules containing 5-nonyl salicylaldoxime. WATARI, H., and HATAKEYAMA, S., Anal. Sci., 1991, 7, (3), 487–489.
  • Encapsulation of 5-aminosalicylic acid into Eudragit RS microspheres and modulation of their release characteristics by use of surfactants. WATTS, P. J., DAVIES, M. C., and MELIA, C. D., J. Controlled Release, 1991, 16, (3), 311–318.
  • A method for preparation of liposomes with encapsulated peptide antigens and surface-linked sugar residues. WEISSIG, V., LASCH, J., and GREGORIADIS, G., Pharmazie, 1991, 46, (1), 56–57. Liposome mediated in vitro transfection of pancreatic islet cells. WEI.SH, N., OBERG, C., HELLERSTROM, C., and WELSH, M., Biomed. Biochim. Acta, 1990, 49, (12), 1157–1164.
  • Microcapsules through polymer complexation. II. By complex coacervation of polymers containing a low charge density. WEN, S., XIAONAN, Y., STEVENSON, W. T. K., and ALEXANDER, H., Biomaterials, 1991, 12, (5), 479–488.
  • Microcapsules through polymer complexation. I: Complex coacervation of polymers contain-ing a high charge density. WEN, S., YIN, X. N., and STEVENSON, W. T., Biomaterials, 1991, 12, (4), 374–384.
  • Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. WESTER, R. C., PATEI., R., NACHT, S., LEYDEN, J., MELENDRES, and MAIBACH, H., J. Am. Acad. Dermatol., 1991, 24, (5, Pt 1), 720–726.
  • Uptake of fungal cells by epidermal langerhans cells and subsequent fungicidal activity when incubated with liposome encapsulated amphotericin B. WETZEL, S. A., CUA, D. J., ADLER-MOORE, J. P., and SPERRY, P. J., Clin. Res., 1991, 39, (2), 534A.
  • Synaptophysin. A widespread constituent of small neuroendocrine vesicles and a new tool in tumor diagnosis. WIEDENMANN, B., Acta Oncol., 1991, 30, (4), 435–440.
  • Definition of optimal conditions of embolization of the drug carrier albumin microspheres in solid tumors of liver. WILLMOTT, N., ANDERSON, J., ANGERSON, W., MCARDLE, C. S., and COOKE, T. G., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 420.
  • Abnormal vasculature of solid tumours: significance for microsphere based targeting strategies. WI LLMOTT, N., GOLDBERG, J., ANDERSON, J., BESSENT, R., Mc Ki LLOP, J., and
  • MCARD1,E, C., Int.Radiat. Biol., 1991, 60, (1-2), 195–199.
  • Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. WINN, S. R., TRESCO, P. A., ZIELINSKI, B., GREENE, L. A., jAEGER, C. B., and AEBISCHER, P., Exp. Neurol., 1991, 113, (3), 322–329.
  • The use of paramagnetic beads for the detection of major histocompatibility complex class I and class II antigens. WORLOCK, A. J., SIDGWICK, A., HORSBURGH, T., and BELL, P. R., Biotechniques, 1991, 10, (3), 310–315.
  • Patch clamping VDAC in liposomes containing whole mitochondrial membranes. WUNDER, U. R., and COLOMBINI, M., J. Membr. Biol., 1991, 123, (1), 83–91.
  • Lung targeting via intravenous administration of microencapsulated chemotherapy. WYGODA, M., CATANE, R., REINER, V., WARNER, E., BREUER, R., SHERMAN, Y., DRAKOS, P., and BEN-SASSON, S., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 419.
  • Liposomes containing dexamethasone-ophthalmic ointment. WYLCEGALA, E., and DZIERCECA, A., Klin. Oczna, 1991, 93, (2-3), 68–69.
  • Incorporation of histone into liposomes increases the efficiency of liposome-mediated gene transfer. YAGI, K., NISHIKIMI, M., and HAYASHI, Y., J C lin. Biochem. Nutr., 1991, 10,(1), 21–26.
  • Effect of sulfatide-inserted liposomes containing entrapped adriamycin on metastasized cells in lymph nodes. YAGUCHI, T., YAMAUCHI, M., TAKAGI, H., OHISHI, N., and YAGI, K., J. Clin. Biochem. Nutr., 1990, 9, (2), 79–85.
  • Antioxidant activity of ubiquinol in solution and phosphatidylcholine liposome. YAMAMOTO, Y., KOMURO, E., and NIKI, E., J. Nutr. Sri. Vitaminol., 1990, 36, (5), 505–511.
  • Potential value of cetylmannoside-modified liposomes as carriers of macrophage activators to human blood monocytes. YAMASHITA, C., SONE, S., OGURA, T., and KIWADA, H., Jpn. J. Cancer Res., 1991, 82, (5), 569–576.
  • Thrombolytic effect of liposomal pro-urokinase. YANO, K., MURAHAMI, K., YUUKI, T., MATSUDA, H., and WATANABE, M., Jpn. f. Pharmacol., 1991, 55, (Suppl. 1), 146P.
  • Liposome flow injection immunoassay: model calculations of competitive immunoreactions involving univalent and multivalent ligands. YAP, W. T., LOCASCIO-BROWN, L., PLANT, A. L., CHOQUETTE, S. J., HORVATH, V., and DURST, R. A., Anal. Chem., 1991,63, (18), 2007–2011.
  • T4N5 liposomes reduce UV mutagenesis in mammalian cells by increasing dimer repair and reducing the patch size. YAROSH, D. B., KIBITEL, J., YEE, V., GREEN, L., and MITCHELL, D., Photochem. Photobiol., 1991, 53, (Suppl.), 29S.
  • Enhanced unscheduled DNA synthesis in UV-irradiated human skin explants treated with T4N5 liposomes. YAROSH, D. B., KIBITEL, J. T., GREEN, L. A., and SPirsowurz, A., J. Invest. Dermatol., 1991, 97, (1), 147–150.
  • Immunologic aspects of liposomes for medical applications. YASUDA, T., Yukagaku, 1991,40, (7), 541–548.
  • The study of microencapsulation for acetaminophen granules. YEH-MING-KUNG, and RAU-MING-YUAN, WANG-DA-PENG., Chung-hua Yao Hsueh Tsa Chih, 1991, 43, (2), 165–174.
  • Phosphatidyl choline and lysophosphatidyl choline in mixed lipid micelles as novel drug delivery systems. YESAIR, D. W., Phospholipids: Biochem. Pharm. Anal. Consid., (Proc. Int. Colloq. Lecithin), 5th, 1989, Plenum, New York, N.Y., USA; publ. 1990, pp. 83–106. Eds: I. Hanin and G. Pepeu.
  • Interaction of humic substances with liposomes. YOSHIDA, S., SHINOZUKA, N., WATANABE, T., and HAYANO, S., Yukagaku, 1991, 40, (6), 478–483.
  • Anti-metastatic activity in vivo of MDP-L-alanyl-cholesterol (MTP-Chol) entrapped in nanocapsules. Yu, W. P., BARRATT, G. M., DEVISSAGUET, J. P., and PUISIEUX, F., Int. J. Immunopharmacol., 1991, 13, (2-3), 167–173.
  • Microencapsulation of DNA-recombinant cells and its application in production of HBsAg. YUAN-ZHONGYI, Li-SHIYUN, LI-XIONG, CHEN-PEIYING, WANG-YUAN, and WU-XIANGFU, Ann. N.Y. Acad. Sci., 1990, 613, (Enzyme Eng. 10), 338–346.
  • Fatty acid binding protein removes fatty acids but not phospholipids from microsomes, liposomes and sonicated vesicles. ZANETTI, R., and CATAI.A, A., Mol. Cell. Biochem., 1991, 100, (1), 1–8.
  • Interactions between pressure and ethanol on the formation of interdigitated DPPC liposomes: a study with Prodan fluorescence. ZENG, J. W., and CHONG, P. L., Biochemistry, 1991,30, (39), 9485–9491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.